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Background: Complications of unsafe abortion is one of the top causes of maternal 
morbidity and mortality among women and adolescent girls globally. Stigmatising attitudes 
and behaviour seem to directly impact women’s and girls’ reproductive decision-making but 
are rarely explored. Enhanced understanding of the stigmatisation of abortion and 
contraceptive use is needed to reduce its impact on affected individuals and increase access 
to quality abortion care and contraceptive counselling and provision.  
 
Aim: The overall aim of this doctoral thesis was to increase knowledge on the constituents 
and consequences of, and solutions to, social stigma surrounding abortion and contraceptive 
use among women seeking post-abortion care, as well as secondary school students, in 
Kisumu, Kenya. 
 
Materials, Methods, and Findings: Study I was a qualitative study with individual, face-
to-face interviews with nine women seeking post-abortion care. The objective was to analyse 
decision-making processes preceding abortion among women and adolescent girls with 
unwanted pregnancies. Method: Over all, 15 in-depth interviews using open-ended questions 
and a non-judgmental approach were conducted among women aged 19–32 years, with 
experienced induced abortion. All interviews were coded manually using inductive content 
analysis. Findings: The main findings showed poor social support and deviation from 
family- and gender-based norms determined abortion decision-making among women and 
girls. Strategic choices concerning whom to trust were made to avoid ignominy, which 
contributed to a culture of silence. The study found that abortion stigma hindered access to 
safe abortion services.   
 
Study II was a sub-study nested in a randomised, controlled trial on women seeking post-
abortion care, focusing on pregnancy intentions in order to investigate contraceptive uptake 
and identify factors associated with unplanned pregnancy. Method: The analysis was based 
on follow-ups with 807 women and adolescent girls, aged 14–45 years, seven to ten days 
after their post-abortion care, preceding additional follow-ups with a subset of 472 women 
after three months. Descriptive statistics and binary logistic regression were used for the 
statistical analysis. Findings: Of the respondents (N = 807), 375 (46.3%) reported unplanned 
pregnancy, and 432 (53.3%) reported planned pregnancy. Regardless of reported pregnancy 
intention, most women started to use a contraceptive method after abortion: 273 (72.8%) of 
the unplanned pregnancy group and 338 (78.2%) of the planned pregnancy group, 
respectively (p = 0.072). Independent factors associated with unplanned pregnancy were 
young age (14-20 years) odds ratio (OR) 1.18; 95% confidence interval (CI), 1.05–2.82; p = 
0.033; unmarried status OR 9.15; 95% CI, 5.72–14.64; p < 0.001; no previous children OR 
1.97; 95% CI, 1.29–3.01; p = 0.002; hidden pregnancy OR 7.71; 95% CI, 3.30–18.01; p < 
0.001; and the partner absent at the clinic visit OR 3.17; 95% CI, 2.21–4.55; p < 0.001. At 
the three-month follow-up, there was no difference in contraceptive use between those 
groups, unplanned (161; 77.4%) versus planned (193; 73.7%), p = 0.350, indicating that 
women seeking post-abortion care may hide their pregnancy intentions. 
 
Study III was a quasi-experimental study with pre- and post-tests, aiming to measure 
attitudes towards abortion and contraceptive use, and to evaluate a stigma-reduction 
intervention among secondary school students. Method: Two validated 5-point Likert scales 
were used for the data collection. The data was self-reported through classroom surveys at 
baseline, prior to initiation of the intervention, and at 1-month and 12-month post 
intervention. Findings: In total, 1,207 students (618 females and 582 males) 13–21 years old 
were included in the analysis at baseline. Abortion was considered sinful, bringing shame to 
the family and community, and contraceptive use was associated with immorality and 
promiscuity. However, male students displayed higher stigma scores: abortion stigma 
(57.7%) and contraceptive use stigma (58.5%), compared to female students (49.0%, p = 
0.003 and 50.6%, p = 0.007, respectively). At 12-month follow-up, the decrease for the 
abortion stigma was 26.5% among the girls, and 29.8% among the boys. The stigma score 
regarding contraceptive use decreased with 25.2% among the girls, and with 28.8% among 
the boys. Hence, the intervention was considered effective to reduce stigma associated with 
abortion and contraception among both girls and boys. The overall stigma scores decreased 
significantly between baseline and 12-month; for abortion 28.2% (2.52±0.55, 1.81±0.54; p < 
0.001) and for contraceptive use 27.2% (2.68±0.83, 1.95±0.70; p < 0.001). 
 
Conclusions: Stigma violates women’s and girls’ rights to sexual and reproductive education 
and services. Social stigma can manifest as negative stereotypes and discrimination, and it 
contributes to a culture of silence around abortion and unintended pregnancy, resulting in 
delayed health care and missed opportunities for contraceptive counselling. Women and girls 
might not disclose an unplanned pregnancy to avoid coercion from health-care providers. 
Girls associated with abortion and contraceptive use were highly stigmatised among their 
peers. A stigma-reduction programme within comprehensive sexuality education could be 
effective. However, to sustain the positive effect among students and to create a sociocultural 
environment where women and girls are empowered to make reproductive decisions, 
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CONCEPTS AND DEFINITIONS  
 
 
Comprehensive abortion care  abortion services at the request of the woman/girl, 
together with contraceptive counselling, provision 
and follow-up  
 
Gender equality equal opportunities, rights, and responsibilities of 
women and men / girls and boys  
 
Gender equity recognises that there are differences between 
women and men and focuses on meeting both sexes’ 
needs, whether similar or different 
 
Maternal death death of woman while pregnant or within six weeks 
of pregnancy termination that is not related to 
accidental or incidental causes 
 
Maternal mortality ratio  number of maternal deaths per 100,000 live births 
 
Post-abortion care  treatment of incomplete abortion and complications 
that could be life-threatening, often after an unsafe 
abortion; response to women’s emotional and 
physical health needs through counselling, 
contraceptive counselling to all women; and 
    service provider and community partnerships for 
prevention (of unintended pregnancy and unsafe 
abortion) 
 
Unsafe abortion  induced abortion by an individual lacking the 
required competencies or performed in an 
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1 INTRODUCTION  
1.1 SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS  
 
Sexual and reproductive health and rights refer to the right to make decisions about, and have 
control over, your body and sexuality (1, 2), as well as the right to achieve the highest possible 
standard of sexual and reproductive health care, free of stigma, force, discrimination and 
violence. Sexual and reproductive health and rights maintain that women, men and 
adolescents should have an enjoyable and safe sex life, as well as the freedom to choose if, 
when and how often to reproduce. This perspective includes the right of women, men and 
adolescents to be accurately informed and to have access to high quality, effective, acceptable 
and affordable modern contraceptive methods (1, 2). 
 
Sexual and reproductive health and rights have a central role in all people’s lives and are 
necessary for their general health and well-being (2). However, it was not until 1994, at the 
International Conference on Population and Development (ICPD) in Cairo, that reproductive 
health was envisioned in a new way with respect to the relationship between population, 
development and individual well-being. The ICPD Programme of Action provided a new 
dimension to population and development programming by placing gender equality, 
women’s empowerment and reproductive health and rights at the centre (1).  
 
After the ICPD in Cairo, the Fourth United Nations World Conference on Women was held 
in Beijing in 1995, where the Beijing Platform for Action was adopted by 189 countries. The 
Beijing Platform for Action represented a decisive moment for the global agenda for gender 
equality and is considered an important global policy framework for women’s rights. Today, 
the commitments and objectives set in Beijing are still used as measurements for achieving 
equality between boys and girls, men and women (3).  
 
In 2000, at the Millennium Summit in New York, the United Nations Member States adopted 
the Millennium Development Goals, comprised of eight development goals intended to 
measure progress on poverty reduction in low- and middle-income countries through 2015 
(4). Goal 5 of the Millennium Development Goals was to improve maternal health. However, 
the Millennium Summit failed to build on the ICPD Programme of Action and Beijing 
Platform for Action, as they initially ignored the importance of sexual and reproductive health 
and rights due to fear that Member States would not adopt the goals. Consequently, donors 
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and governments focused their efforts on other issues (5). It was only at the World Summit 
in 2005 that the Member States reaffirmed the commitment to sexual and reproductive health 
and declared that universal access to reproductive health is fundamental to achieve the 
Millennium Development Goals. Consequently, in late 2007, the target related to universal 
access to reproductive health was added to Goal 5 to improve maternal health (5).  
 
In 2015, the United Nations General Assembly reinforced the Millennium Development 
Goals with 17 new Sustainable Development Goals and 169 targets for the global focus on 
advancing human development by 2030 (6). The 2030 Agenda for Sustainable Development 
was set up by the world leaders with the aim of leaving no one behind. This time, gender 
equality and women’s empowerment was an integral part of each goal, and sexual and 
reproductive health was emphasised under Goal 3 with the target of ensuring universal access 
to sexual and reproductive health-care information, education and services (7). Also, the 
development of “The Global Strategy for Women’s, Children’s and Adolescents’ Health 
(2016–2030)” further enforced the importance of health goals. This strategy builds on the 
United Nations Secretary-General’s “2010 Every Woman Every Child” movement (8).  
 
In 2018, the “Guttmacher-Lancet Commission on Sexual and Reproductive Health and 
Rights” launched a report highlighting the progress made in relation to sexual and 
reproductive health and rights, and what still needs to be done (2). The report openly 
criticized the 2030 Agenda for Sustainable Development and the universal health coverage 
movement for their narrow interpretation of sexual and reproductive health and rights. (They 
only include components such as maternal and newborn health, HIV/AIDS, and 
contraception, while issues like abortion and social stigma are overlooked.) Over the last few 
decades, improvements have been seen in reproductive health, but women, men and 
adolescents still have insufficient access to comprehensive sexual and reproductive health 
information, education, and services, and their sexual and reproductive rights are overlooked 
and disrespected (2). A more holistic approach to sexual and reproductive health is needed 
to accelerate progress. Some of the neglected issues are gender-based violence, abortion, 
adolescent sexuality, and diversity in gender identity and sexual orientation. Also, barriers to 
accessing sexual and reproductive health and rights, such as national laws, policies, social 
norms and values, must be confronted (2).  
 
In 2019, ICPD25 took place in Nairobi, Kenya, and the partners recommitted to the 
Programme of Action conceived at the ICPD in Cairo in 1994: gender equality and sexual 
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and reproductive health and rights for all. Once again, it was determined that sexual and 
reproductive health and rights are interlinked with gender equality and equity, as women are 
the ones to give birth and usually bear most of the responsibility to feed, care, and educate 
children (9). Although numerous international (legal and political) agreements about sexual 
and reproductive health and rights have been developed and ratified, not all Member States 
of the United Nations have endorsed these agreements. At the 2019 United Nations General 
Assembly, 19 countries, United States of America, Bahrain, Belarus, Brazil, Democratic 
Republic of the Congo, Egypt, Guatemala, Haiti, Hungary, Iraq, Libya, Mali, Nigeria, 
Poland, Russia, Saudi Arabia, Sudan, United Arab Emirates and Yemen (10), announced: 
  
“We do not support references to ambiguous terms and expressions, such as sexual 
and reproductive health and rights in United Nations documents, because they can 
undermine the critical role of the family and promote practices, like abortion, in 
circumstances that do not enjoy international consensus, and which can be 
misinterpreted by United Nations agencies” (10). 
 
Since 1973, the Helms Amendment has banned the use of foreign aid from the United States 
for activities related to abortion. In 1984, at the International Conference on Population in 
Mexico City, the restrictions were further strengthened by the United States government 
under the Reagan Administration. Under the New Mexico City Policy (sometimes called the 
Global Gage Rule), non-governmental organizations that included abortion-related activities 
in their programme would not receive funding from the United States Agency for 
International Development. The Mexico City Policy has been imposed by all subsequent 
Republican Administrations and similarly repealed by all Democratic Administrations. 
Republican President Donald Trump, the current President of the United States, reinstated 
the Mexico City Policy in January 2017 (11). 
 
The constant denial of women’s right to independently make decisions regarding their own 
bodies violates or poses a threat to several human rights treaties and instruments, such as a 
“woman’s right to equality, privacy, non-discrimination, health”, and freedom from 
inhumane and degrading treatment, as pronounced by the United Nations (12, 13). Access to 
information, education, and services surrounding comprehensive sexual and reproductive 
health and rights are fundamental human rights, and must be prioritised to ensure women’s 
and adolescent girls’ empowerment and gender equality (2, 9, 14). All people have the right 




2.1 MATERNAL MORBIDITY AND MORTALITY  
 
Maternal mortality reduction remains a global development priority and was embraced in the 
Sustainable Development Goals agenda through 2030 under “Goal 3: Ensure healthy lives 
and promote well-being for all at all ages” (7). Furthermore, under Goal 3, an ambitious 
global target has been set up, “reducing the global maternal mortality rate to less than 70 per 
100,000 births, with no country having a maternal mortality rate of more than twice the global 
average” (7). 
 
Pregnancy-related complications are a leading cause of morbidity and mortality for women 
and adolescent girls of reproductive age in low-income countries (15). Maternal mortality 
refers to the death of a woman or adolescent girl while pregnant or within six weeks of 
pregnancy termination that is not related to accidental or incidental causes (16). According 
to the World Health Organization, maternal morbidity is “any health condition attributed to, 
and/or aggravated by, pregnancy and childbirth that has a negative impact on the woman’s 
well-being” (17). Of all public health indicators, maternal mortality numbers show the 
greatest level of inequality among countries. Each year, approximately 295,000 women and 
adolescent girls of reproductive age die from pregnancy- or childbirth-related complications. 
Nearly all (94%) of these deaths happen in countries of low or lower middle income, and 
most could be prevented. The maternal mortality is greatest in sub-Saharan Africa and South 
Asia, which account for 86% (254,000) of all maternal deaths globally. About two-thirds 
(196,000) of all maternal deaths globally occur in sub-Saharan Africa alone (16). Among 
adolescent girls (15–19-year-old), pregnancy and childbirth complications are the most 
common cause of death globally, but low- and middle-income countries account for almost 
all (99%) maternal deaths of adolescent girls aged 15–19 years (18). Maternal deaths among 
girls younger than 15 years occur; however, the number of deaths is uncertain, as many 
countries are not registering them as maternal deaths (16).  
 
Instead of the direct number of maternal deaths, maternal mortality is often estimated in the 
maternal mortality ratio, which is “the number of women who die during pregnancy and 
childbirth, per 100,000 live births” (16). The 2017 global maternal mortality estimates 
indicate that maternal deaths per 100,000 live birth decreased from 342 to 211 (38%) between 
2000 and 2017 (16). Also, sub-regional achievements were noted: sub-Saharan Africa has 
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achieved a significant reduction in maternal deaths (40%) since 2000 (16). Despite these 
achievements, maternal mortality is disproportionally higher in low-income countries, which 
highlights global inequalities and inequities in health and resources. The maternal mortality 
ratio is significantly higher in low-income countries: 462 per 100,000 live births compared 
to 11 per 100,000 live births in high-income countries (16).  
 
The risk of maternal morbidity and mortality has two components: the fertility risk—that is, 
the risk of getting pregnant—and the risk of developing a complication while pregnant, in 
labour or postpartum (19). Therefore, women in low-income countries are at higher risk of 
maternal mortality and morbidity as they, on average, have more pregnancies during their 
life course compared with women in high-income countries. The lifetime risk of maternal 
mortality is the likelihood that a 15-year-old adolescent girl will die from a pregnancy-related 
complication. In low-income countries, the probability is 1 in 45, whereas in high-income 
countries, the probability is 1 in 5,400 (16). Also, adolescent girls aged 10–19 years have an 
increased risk of negative pregnancy outcomes compared to women in their early twenties 
(20–24 years), and the risk of maternal death is highest among adolescent girls under 15 years 
old (20, 21). 
 
The causes of maternal morbidity and mortality are well documented and comprise severe 
bleeding, infection, complications of unsafe abortion, high blood pressure (preeclampsia and 
eclampsia), and obstructed labour. Global estimates indicate that about 4.7%–13.2% of all 
maternal deaths are due to complications of unsafe abortions, as compared to severe bleeding 
(27.1%), infection (10.7%) and hypertensive disorders (14%). In the last two decades, 
maternal deaths caused by severe bleeding, infection, high blood pressure and prolonged 
labour have reduced significantly; however, the proportion of deaths due to unsafe abortion 
remains high (22). 
 
2.2 UNMET NEED FOR CONTRACEPTION 
Unmet need for contraception represents the gap between sexually active women’s and 
adolescent girls’ wish to avoid future pregnancy and the use of modern (effective and 
accepted) contraceptives (23). Unmet need for contraception is a theoretical concept for 
estimating the possible demand for contraception. International organizations and family 
planning programmes have used the concept mainly for advocacy purposes (25).  
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Recent estimates indicate that 218 million women and adolescent girls in low- and middle-
income countries have an unmet need for modern contraception. These women and 
adolescent girls desire to postpone pregnancy or have finalised childbearing; however, they 
are not using a modern contraceptive method (24).  
The use of modern contraceptives in low-income countries is hampered by poor access to 
high-quality sexual and reproductive health services and fragile government programmes 
(26). Access to health care has been widely analysed, and Orbit et al. provide a framework 
for access to health care in low-income countries, which includes “Five Dimensions of 
Access to Health Care Services”: (a) availability, (b) accessibility, (c) affordability, (d) 
adequacy and (e) acceptability (27). This explanation is unfortunately overgeneralised with 
respect to contraception. In the last decade, researchers have shown that the issue of unmet 
need for contraception is a more complex situation (28). A systematic review of the literature 
about positive and negative factors influencing contraceptive use among women and 
adolescent girls in sub-Saharan Africa between 2005 and 2015 indicated that underlying 
barriers to contraceptive use include: anxiety about side effects, male partners’ disapproval, 
and social norms and cultural values related to women’s and adolescent girls’ fecundity. 
Education, employment, and communication with male partners were found to be positive 
factors for women’s and adolescent girls’ contraceptive use. In other words, low modern 
contraceptive use in sub-Saharan Africa is due to societal, cultural and personal barriers, 
where societal barriers include poor access to health services, cultural barriers refer to norms 
regarding female sexuality, and personal barriers are a more complex pattern of negative 
perceptions and misinformation (28).  
 
2.3 UNINTENDED PREGNANCY 
The unintended pregnancy rate is a standard indicator for measuring women’s and adolescent 
girls’ control over their reproductive lives. This metric was introduced in the 1940s and is 
still used broadly in sexual and reproductive health research, policy, and programme planning 
(29, 30). Unintended pregnancy is traditionally defined as pregnancies that are either 
unplanned, mistimed or unwanted. Conversely, pregnancies that occurred as planned, later 
in life than the woman wanted, or for women who are indifferent about the pregnancy are all 
considered intended (29). Globally, the prevalence of unintended pregnancy is highest in 
low-income countries, particularly in sub-Saharan Africa. However, a recent study suggests 
that the global unintended pregnancy rate has declined between 1990–1994 and 2015–2019, 
from 79 unintended pregnancies per 1,000 women to 64 unintended pregnancies per 1,000 
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women, but the proportion of unintended pregnancies with abortion as the outcome has 
increased (30). The same study suggests that globally about 121 million unintended 
pregnancies occur annually among women and adolescent girls (15–49 years). Unfortunately, 
the authors have not segregated unintended pregnancy by age (30). However, a study from 
2016 suggests that about 10 million unintended pregnancies occur each year among 
adolescent girls (15–19 years) in low-income countries (31), but it is difficult to compare 
these estimates with the recent 2020 study as they used different models.  
Unintended pregnancy has been classified as an extensive public health problem (32) and is 
also recognized as a cause and consequence of socioeconomic inequality (33). Lack of 
awareness of contraceptive methods, contraceptive failure, improper and inconsistent 
condom use, and modest knowledge of emergency contraception are believed to be key 
reasons for the high prevalence of unintended pregnancy (34, 35). Consequently, public 
health programmes have concentrated on increasing awareness of and access to contraceptive 
services as a method to reduce unintended pregnancy. These efforts are needed, of course, 
but will not include the larger sociocultural context in which reproductive decision-making 
occurs (36).  
Unintended pregnancy is a subjective indicator and may not truthfully or fully capture 
women’s and adolescent girls’ feelings regarding the pregnancy at the time of conception. 
Since 1940, people’s perceptions of sexuality and fertility have changed, and political, 
economic and cultural changes have taken place (29, 37). The concept of unintended and 
intended pregnancy behaviour is limited, particularly among low-income populations that do 
not necessarily classify their pregnancy in this binary way (36).  
2.4 UNSAFE ABORTION  
In 1967, the World Health Assembly recognized abortion as a serious public health problem 
(38). However, it was not until 1987 that the Safe Motherhood Initiative introduced the 
concept of “unsafe abortion," with the objective of emphasising the public health issue rather 
than the legal aspects of abortion. Moreover, it was only in 1989, when the World Health 
Organization published the first abortion-related maternal death estimates, that the magnitude 
of this public health concern was really understood (39). The World Health Organization 
defines unsafe abortion as a procedure of terminating an unwanted pregnancy by individuals 
missing the required competencies or in a setting not in compliance with minimal medical 




“The persons, skills and medical standards considered safe in the provision of 
abortion are different for medical and surgical abortion and also depend on the 
duration of the pregnancy. What is considered ‘safe’ should be interpreted in line with 
current World Health Organization technical and policy guidance” (40).  
 
The latest global estimates suggest that about 73.3 million induced (safe and unsafe) 
abortions occurred globally every year between 2015 and 2019 (30). Estimates from 2010 to 
2014 suggest that about 45% of all abortions were unsafe and nearly all took place in a low-
income country (41). In East Africa alone, about 2.7 million abortions occur annually, and 
most of these abortions are conducted in an unsafe way (42). It is estimated that globally 
about 5.6 million abortions occur annually among adolescent girls (15–19 years), and out of 
these, 3.9 million are unsafe (31). Approximately 7 million women and adolescent girls are 
admitted to hospitals every year in low-resource settings due to complications of unsafe 
abortions (43). Unsafe abortion is one of the top five causes of maternal death, although it is 
completely preventable (22).  
 
The determinants for unsafe abortion are many, but examples include the national laws and 
policies on abortion, the socioeconomic and political conditions, the need for confidentiality, 
availability of safe abortion services, perceived higher cost of safe providers, lack of 
knowledge about safe abortion procedures and services, and stigma surrounding abortion (44, 
45). In high-resource settings, almost all abortions are safe, but this is not the case in low-
resource settings. For instance, in Africa it is estimated that only one in four abortions are 
safe (41). Since the 1990s, maternal deaths caused by unsafe abortion have steadily increased 
in sub-Saharan Africa (46), and it is estimated that about 30% of all maternal deaths in this 
region are due to complications from unsafe abortion (43). Adolescent girls in low-resource 
settings, and predominantly those living in rural areas, are more likely to have an unsafe 
abortion, compared to women in high-income countries, indicating enormous health 
inequities and inequalities. Although unsafe abortion is known to be a serious public health 
concern, the nature of the problem has left it out of the global strategies to combat maternal 
mortality (47). Moral and religious arguments hamper political commitment and legal 
reforms that are needed to increase access to high-quality abortion care. Therefore, unsafe 





Despite legal restrictions, women and adolescent girls undergo abortion. These legal 
restrictions and societal stigma may drive the procedure underground, where it becomes 
unsafe and harmful to women's and adolescent girls' health, lives, families, and communities. 
Unsafe abortion is mainly a problem in countries where abortion is criminalized by law or 
where, although legally permitted, safe abortion is not available or accessible. In these often 
low-resource settings, women and adolescent girls undergo unsafe abortions by self-inducing 
or attaining unsafe abortions from traditional healers or paramedical workers (48). 
Furthermore, when legal access to abortion is restricted and health-care resources are scarce, 
women and adolescent girls tend to present at later gestations with incomplete abortion or 
complications caused by unsafe abortion, and incompetent health-care providers use outdated 
post-abortion care methods—all contributing to increased risk for maternal death (49). 
 
2.5 INTERVENTIONS TO DECREASE UNSAFE-ABORTION-RELATED 
MORBIDITY AND MORTALITY  
 
“The Committee on the Elimination of Discrimination Against Women” clearly states that 
restrictive abortion laws and lack of access to reproductive education and modern 
contraceptive methods are linked with high prevalence of maternal deaths related to unsafe 
abortion (12). Prevention of unsafe abortion includes: (a) prevention of unintended 
pregnancy and induced abortion through access to rights-based contraceptive counselling and 
services, (b) assurance of safe and legal abortion, (c) provision of high-quality post-abortion 
care to prevent complications of unsafe abortion, and (d) prevention of repeated abortion 
through post-abortion contraceptive counselling and services (50).  
2.5.1 Access to rights-based contraceptive counselling and services  
 
Sustainable Development Goal 3.7 (“universal access to sexual and reproductive health-care 
services”) recognizes access to contraception as a human right (7). Women and adolescent 
girls with unmet need for contraceptives may choose not to use contraception for various 
reasons, including low decision-making power, laws and policies preventing unmarried 
women from accessing contraceptives, misconceptions, side effects, stigma, and poor 
geographical and/or financial access (51, 52). Adolescent girls in low-income countries, and 
more so unmarried adolescent girls, face multiple barriers in accessing contraceptives and in 
using them correctly and consistently (52). Supporting women and adolescent girls in 
accessing contraceptives and fulfilling their pregnancy preferences is a high priority by 
development partners. In 2012, at the London Summit of Family Planning, a global 
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partnership called FP2020 was launched with the objective of increasing new users of modern 
contraceptives by 120 million in the most underprivileged countries by 2020 (53). 
 
In 2017, FP2020 partnered with representatives from non-governmental organizations 
(NGOs), donors and the United Nations to develop strategies for improving contraceptive 
counselling and rights-based service provision. One high-level recommendation is that 
governments should commit to protect, respect and fulfil the human right to freely decide 
when to have children and to respect the choices the individuals make. Another 
recommendation is that countries should implement a “Client-Centred Approach to Care” in 
order to empower individuals to achieve their reproductive goals. Box 1 outlines the FP2020 
definition of “Client-Centred Approach to Care” (54).  
 
This approach is in line with the theoretical framework developed three decades ago by Bruce 
J. on the quality of family planning services, which is focused on (a) high-quality two-way 
information provision, (b) contraceptive technology safety, (c) choice of contraceptive 
method, (d) interpersonal relations, (e) follow-up care, and (f) integration with other sexual 
and reproductive health services (55). Also, in 2006, the World Health Organization 
published a guide for providers, policymakers and health managers with a systematic method 
to operationalize interventions to improve quality of care (56). A year later, in 2007, the 
World Health Organization published the first edition of the Global Handbook, entitled 
“Family Planning: A global handbook for providers.” The handbook is written in plain 
English as a quick reference for health-care providers working in low-income countries. The 
third edition of this handbook was published in 2018 and includes a section on quality of care 
that stresses the importance of interpersonal relations, respectful counselling, dignity, privacy 
and confidentiality (57). 
Box 1: FP2020 Client-Centred Approach to Care 
1. Clients are treated with dignity and respect; privacy, confidentiality, and consent are ensured. 
2. Clients are asked about their reproductive aims, family situation, previous contraceptive use and 
chosen method(s); information is offered regarding various contraceptive methods that could fit the 
clients’ needs.  
3. Contraceptive options are discussed, including possible side effects and their management. Clients 
select their ideal method, or no method, after being well-informed.  
4. Users receive follow-up and, if they desire, are provided a method switch.  
5. Communities are encouraged to demand high-quality information, contraceptives, services, and care. 
Source: FP2020; “Call to action: Strategies for Enhancing Quality of Care in the Context of Rights-
based Family Planning” (54) 
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2.5.2 Legal abortion 
Prior to the nineteenth century, abortion was not forbidden by law, but by the end of the 
nineteenth century abortion was legally restricted in almost every country. Powerful 
European countries, such as France, Great Britain, Italy, Portugal and Spain, forced their own 
abortion laws on their colonies (58). The reasons for introducing legal restrictions on abortion 
services were mainly threefold. First, women were dying due to unsafe abortion, and the laws 
were set up to protect women. Second, abortion was seen as a sin, and the laws were intended 
to restrict and penalise women. Finally, the laws were intended to protect the foetal life (58).  
Abortion is one of the few health interventions that are regulated by law. National abortion 
laws still regulate women’s fertility and permit, forbid or restrict abortion services. However, 
in most high-income countries, the liberalization of abortion laws occurred between 1950 
and 1985 due to safety and human rights issues (59). Evidence showed that restricting or 
criminalizing abortion could not reduce abortion rates; however, it affected the safety of 
abortion provision (50). The success of liberalization efforts largely depends on the political 
situation and commitment of advocacy groups in the country. The most liberal abortion law 
permits a woman and an adolescent girl abortion upon her request. The United Nations has 
identified seven different grounds on which abortion is permitted: (a) to protect the woman’s 
life, (b) to preserve health, (c) to preserve mental health, (d) in case of rape or incest, (e) for 
foetal defects, (f) for socioeconomic reasons and (g) on request (60).  
In 1995, the Beijing Platform of Action announced the importance of removing legal barriers 
to abortion in order to save women’s lives, promote their health and empower women to 
make decisions about their reproductive health (41). However, in 2018, only 32% of all 
countries in the world allowed or permitted abortion at the woman’s request with no need for 
justification. Most countries (82%) permitted abortion to save the woman’s life, but only 
about half of the countries (46%) allowed or permitted abortion when the pregnancy resulted 
from rape. In general, abortion laws and policies are significantly more restrictive in low-
income countries (61). Abortion laws are restrictive in most countries in Africa. In only five 
African countries (Angola, Cabo Verde, São Tomé and Príncipe, South Africa, and Tunisia), 
abortion is legal on request of the woman, with a gestational limit of 12 weeks in all countries, 
except for Angola, where the gestational limit is 10 weeks (62).  
In countries with restricted access to abortion, individuals with unintended pregnancies still 
seek abortion and consequently face legal and physical risks. Restrictive abortion laws do not 
lower the abortion rates—rather the opposite. A recent study found that the abortion rate for 
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countries with restricted abortion laws was 36 (80% UI 32–42) per 1,000 women aged 
between 15 and 49 years, compared to 26 (80% UI 24–30) per 1,000 women aged between 
15 and 49 years for countries with broad legal access to abortion, excluding India and China 
(30).  
Although abortion is legal on various grounds in sub-Saharan Africa, safe abortion is rarely 
available, accessible and affordable for women and adolescent girls. Health-care providers, 
including nurses and midwives, persist in declaring abortion illegal, rather than recognizing 
that women and adolescent girls have a legal right to abortion under certain circumstances. 
Consequently, lawyers, policymakers and health-care professionals ignore these women’s 
and adolescent girls’ right to safe abortion services (63). 
2.5.3 Access to quality comprehensive abortion care  
 
Comprehensive abortion care refers to safe abortion and post-abortion care, including 
contraceptive counselling and services (64). 
2.5.3.1 Safe abortion care 
 
The safe abortion guidance by the World Health Organization suggests that safe abortion 
services are possible at a primary care level and by midlevel health-care providers using 
simple technologies, such as medical abortion (“combination of mifepristone and 
misoprostol, or misoprostol alone where mifepristone is not available”) or manual vacuum 
aspiration (56, 57). Furthermore, the World Health Organization classifies abortion safety 
into three levels: safe, less safe and least safe (41, 58). Abortions performed with a medical 
procedure recommended by the World Health Organization, appropriate for gestational age 
and by a skilled health-care provider are defined as safe. Less safe are abortions that meet 
one of two criteria—provider or medical procedure—but not both. Similarly, abortions 
performed with outdated methods, even if the provider has the competencies, are considered 
less safe. The least safe are abortions that meet neither provider nor medical procedure 
criteria. This could be when an untrained individual uses dangerous procedures or when using 
traditional mixtures or herbs (59).  
 
The World Health Organization estimates that about 55% of all abortions globally are 
considered safe, while 31% are less safe, and 14% are least safe. Countries with restrictive 
abortion laws have higher proportions of least-safe abortions (41). Nevertheless, estimating 
abortion safety is complex. Medical abortion and telemedicine services are more common 
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and reach a larger number of women and adolescent girls; therefore, the challenges in 
estimating abortion safety can be more complicated than what recent studies present. Also, 
data on abortion outcomes, abortion stigma and health-care providers’ competencies should 
also be considered when estimating abortion safety (60). 
2.5.3.2 Post-abortion care  
 
Post-abortion care is an important part of comprehensive abortion care for the treatment of 
complications from both spontaneous and induced abortion. By treating complications 
related to unsafe abortion or incomplete abortion, post-abortion care can be lifesaving (65).  
 
In 1991, Ipas, an international, nongovernmental organization based in the United States, 
used the term “post-abortion care” for the first time in their strategic planning document, with 
the objective of breaking the cycle of repeated unintended pregnancies and improving 
women’s health. A few years later (1993), Ipas, the International Planned Parenthood 
Federation (IPPF), AVSC International (now EngenderHealth), the JHPIEGO (“International 
non-profit health organisation affiliated with Johns Hopkins University”), and Pathfinder 
International established the Post Abortion Care Consortium with the aim of promoting post-
abortion care as a strategy to improve public health (66). As of today, the post-abortion care 
model consists of five aspects: (a) prevention through community and health-care provider 
partnerships, (b) counselling, (c) treatment, (d) contraceptive services, and (e) referral system 
to other more comprehensive health-care services (64). To prevent future unintended 
pregnancies and repeated abortions, contraceptive counselling and the provision of 
contraceptive methods are essential elements in post-abortion care. Post-abortion 
contraceptive counselling and provision should be offered to all women and adolescent girls, 
along with adequate information about various contraceptive methods for immediate 
provision (50, 67), as ovulation can occur as early as one week after a safe abortion (medical 
or surgical) (67). Furthermore, the motivation to start an effective contraceptive method is 
highest just after the abortion, and most modern methods can be provided immediately. 
Improved post-abortion services, such as enhanced contraceptive counselling, would be 
essential developments for the concerned women and their families (68). 
2.5.3.3 Quality abortion and post-abortion care  
 
For many years, abortion care has been focused on safety, and only recently has the 
discussion on quality abortion and post-abortion care been initiated. Quality abortion care 
includes safety but is not the only element. Consequently, what constitutes quality abortion 
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care is not well defined. Standard or agreed-upon indicators for measuring quality abortion 
care are also absent (69). However, there is a growing awareness of the importance of quality 
abortion and post-abortion care, as opposed to merely safe abortion care (70).  
 
2.6 ADOLESCENTS’ SEXUAL AND REPRODUCTIVE HEALTH  
 
Estimations suggest that about 1.2 billion (16%) of the global population consists of 
adolescents aged 10–19 years. Sub-Saharan Africa is the area with the highest proportion of 
adolescents aged 10–19 years, with 23% of the region’s population belonging to this age 
group (71). Adolescents (age group of 10–19 years) undergo several physical, emotional and 
social changes. This is also the period when many people will start exploring their sexuality 
and developing intimate relationships. In many low-income countries, cultural taboos and 
stigmatising attitudes towards girls’ puberty and sexuality are common. Adolescent girls are 
often poorly prepared for puberty, and the most common sources of information are mothers 
and other female relatives who are not necessarily ready to respond to the needs of the girls. 
Researchers have found that in some low-income countries, two out of three adolescent girls 
were not aware of puberty and did not understand menstruation (72).  
 
Adolescent girls represent an uneven portion of morbidity and mortality from unsafe abortion 
compared to women older than 20 years (73). Typically, adolescent girls understand they are 
pregnant much later than women older than 20 years. Therefore, adolescent girls with 
unwanted pregnancies will have abortions later in the pregnancy period. Also, they tend to 
self-manage an abortion or search for help from unskilled providers due to stigma and 
discrimination. Commonly, adolescent girls and young women are less informed about their 
sexual and reproductive rights, particularly those related to abortion and post-abortion care 
(74). 
2.6.1 High-quality comprehensive sexuality education  
 
Comprehensive sexuality education (CSE) is an age-appropriate, school-based programme 
for learning about the emotional, physical and social aspects of sexuality and reproduction. 
The objective of CSE is to empower adolescents and youth to better understand their 
sexuality, to increase sexual and reproductive health and rights knowledge and skills, to 
explore their values, attitudes and beliefs, and to equip them to be prepared to make healthy 




In 1994, the ICPD Programme of Action emphasised the importance of sexuality education 
for adolescents and young people (1). Consequently, access to CSE is protected today by 
international human rights treaties and recognized by several international bodies, such as 
the United Nations Population Fund (UNFPA), the United Nations Educational, Scientific 
and Cultural Organization (UNESCO), the Joint United Nations Programme on HIV and 
AIDS (UNAIDS), and the World Health Organization (75).  
 
In 2009, UNESCO published the International Technical Guidance on Sexuality Education, 
which provided international standards for CSE programmes and included attention to human 
rights and gender issues (76). Consequently, other CSE tools were developed by UNESCO 
and UNFPA to support the development, scale-up or review of CSE programmes. In early 
2018, UNESCO, together with UNAIDS, UNFPA, United Nations Children's Fund 
(UNICEF), United Nations Women, and World Health Organization, published the revised 
“International Technical Guidance on Sexuality Education” (75,77). With this guidance 
document, the six United Nations agencies provided a commonly agreed upon definition of 
CSE, along with evidence, rationale and directions on CSE programmes. The 2018 revised 
document has improved some key concepts, topics and learning objectives. It also provides 
a strong focus on gender inequalities, gender norms, and human rights. In addition, a strong 
focus on pregnancy and pregnancy prevention, unsafe abortion, and gender-based violence 
was included to respond to current needs (75,77). Regarding discrimination and stigmatising 
attitudes, the revised “International Technical Guidance on Sexuality Education” includes 
one chapter on HIV/AIDS stigma, and the document also raises the issue of stigmatisation 
due to grounds of sexual orientation and gender identity (75). However, stigma associated 
with abortion and contraception is completely excluded and not discussed.  
 
High-quality CSE with a focus on empowerment, gender equality and human rights has been 
shown to improve sexual behaviour, health, knowledge and attitudes. CSE has gained 
widespread acceptance, and several countries worldwide have implemented sexuality 
education policies with the aim of preventing unintended pregnancies, unsafe abortions and 
HIV transmission. However, there is still discomfort and reluctancy about adolescent 
sexuality in many communities. Sexuality education remains controversial, mostly due to the 
fear that informing adolescents about sex and demonstrating condom use will increase sexual 




A reason for poor implementation of the CSE programme could be that teachers are not 
equipped to enable adolescents to personalise what they have learnt at school and apply it in 
their lives. Many teachers in low-income countries are not trained in delivering CSE and 
might have negative and stigmatising attitudes, as well as poor knowledge and skills in 
delivering CSE effectively (79). Teachers’ competencies in providing CSE to adolescents 
and young people are fundamental for high-quality CSE programmes (80). In settings where 
gender inequalities exist and sexual and reproductive health topics are sensitive and formed 
by social and cultural norms, CSE can have a transformative role. CSE can challenge negative 
sexual and reproductive attitudes and contribute to a united society (77).  
2.7 STIGMA ASSOCIATED WITH ABORTION AND CONTRACEPTIVE USE 
The term stigma (plural stigmata) was used by the Greeks to express physical signs placed 
on the body like a tattoo to indicate something unusual or negative about the moral status of 
a person. The physical signs were burnt or cut into the skin and left prominent eschars to 
visually mark that the individual was a traitor, slave or criminal. In other words, the person 
was supposed to be avoided or shunned because he or she was morally polluted. The 
explanation for using stigmata was the concept of group survival. Individuals who were 
perceived as threats or as incapable of contributing to the group’s survival were stigmatised 
(81).  
In 1963, stigma was defined by Goffman as follows:  
“An illuminating excursion into the situation of persons who are unable to conform 
to standards that society calls normal. Disqualified from full social acceptance, they 
are stigmatised individuals” (81 p158).  
The definition of stigma by Goffman emphasises shame and humiliation, rather than physical 
evidence, like the bodily eschar of stigma used by the Greeks. Furthermore, Goffman 
emphasises the contagiousness of stigma: stigma as individual stereotyped attitudes and 
beliefs that originate from the stigmatiser and are directed towards the stigmatised people 
that belong to a less powerful group within the society (81).  
The first definition of abortion stigma was formulated in 2009 by Kumar, Hessini and 
Mitchell as “a negative attribute ascribed to women who seek to terminate a pregnancy that 
marks them, internally or externally, as inferior to ideals of womanhood” (44). Kumar, 
Hessini and Mitchell build on Goffman’s stigma framework and on other social science 
researchers’ (Link and Phelan) concept of stigma by linking labelling, discrimination and 
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stereotyping (82). Additionally, they were influenced by Heijnders and Van Der Meij in 
amplifying how abortion stigma operates at four levels: (a) cultural, (b) organisational, (c) 
community and (d) individual (83). Kumar, Hessini and Mitchell indicate three femininity 
ideologies that adolescent girls and women who obtained abortions are frequently considered 
to have violated: “female sexuality solely for procreation, the inevitability of motherhood 
and instinctual nurturance of the vulnerable” (44 p625-639 ). According to this concept, 
women who have obtained abortions or used contraceptives challenge social norms related 
to maternity and female sexuality, and therefore provoke stigmatising attitudes and behaviour 
from society (44).  
Abortion stigma researchers have developed a three-domain framework to describe how 
women encounter abortion stigma. First, perceived stigma describes a woman’s 
consciousness of others’ attitudes and values towards abortion and her anticipation that the 
society will discriminate against her fertility regulation behaviour. Second, internalized 
stigma results when a woman incorporates adverse attitudes associated with abortion, like 
shame and guilt, into her identity. Finally, enacted stigma describes direct discrimination or 
negative behaviour by the society due to a women’s abortion experience. Women who have 
obtained abortions are probably affected the most by abortion stigma, but discrimination and 
negative attitudes can also spread to groups such as abortion providers, partners and families 
of women who have had abortions (84, 85).  
There is evidence suggesting that a large proportion of women who have had an abortion 
experience internalized abortion stigma in the form of guilt, shame, negative feelings or self-
blame (85). Previous research also indicates that women who have terminated an unwanted 
pregnancy fear possible social reactions and judgement. In many countries, women feel 
uncertainty about the legality, ethics and morality of abortions. Consequently, women tend 
to undergo abortion in secret, which leads to increased social isolation and psychological 
distress (85). Similarly, previous studies have shown that religion is a significant determinant 
of abortion attitudes. For example, when premarital sex is considered a sin, adolescent girls 
associated with contraceptive use are often stigmatised (52, 86). Women’s and adolescent 
girls’ fear of stigma and discrimination associated with abortion and contraceptive use is a 
major barrier for them to access safe and effective sexual and reproductive health services 
(52, 87, 88). “Stigma works at all levels in society, not least in school environments” (89) 
and among abortion providers (90). Research suggests that post-abortion care providers also 
have stigmatising attitudes towards women in need of abortion and contraceptive services.  
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Abortion stigma has commonly been defined as individual-level attributes, beliefs and 
behaviours. However, in recent years, there has been a shift within scholarly literature from 
defining abortion stigma as an individual phenomenon to a sociocultural process including 
power relations (84, 91). Millar (2020) has suggested a broader definition for abortion stigma 
to allow for cultural differences and several objectives:  
“Abortion stigma is a sociocultural process tied to the categories of difference upon 
which power relations are produced and legitimated. Stigma is one of many processes 
through which abortion is made intelligible and is contingent and contested” (91).  
Stigma associated with abortion and contraception, including impressions of coercion, are 
essential factors to consider when aiming for decreased unintended pregnancy rates and 
improved public health. Stigmatising attitudes and beliefs among health-care providers, 
parents and adolescents are barriers to safe abortion and effective modern contraceptive 
methods (52, 92).  
The research field surrounding stigma associated with abortion and contraception is growing. 
However, most studies focus on women, those whom abortion stigma affects, (84) or health-
care providers’ attitudes towards abortion (90). A systematic literature review on abortion 
stigma confirms this, as it found only 14 articles that addressed abortion stigma. Seven 
articles addressed women’s experience of abortion stigma; five articles provided knowledge 
on stigmatising attitudes among the public towards women who opt for an abortion; and three 
articles provided information on providers’ experience of abortion stigma (85). Furthermore, 
the studies included in the systematic literature review were predominantly from one single 
high-income country; 11 out of 14 studies were conducted in the United States (85). 
Improving the understanding of how stigma operates within and between social groups and 
the social production and function of stigma associated with abortion and contraception will 
benefit not only the women and adolescent girls in need but also society in general, as it can 
inform strategies to reduce such stigma. Reduced stigmatising attitudes in society in general 
may eliminate barriers and improve access to abortion information, education and services 
of high quality.  
 
2.8 THE KENYAN CONTEXT   
2.8.1 Demographics  
Kenya is a country with a multifaceted history that attained its independence from Britain in 
1963 and was declared a republic one year later. Kenya has faced times of tribal pressures, 
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and it is only in the last ten years that the country has seen some stability and developmental 
progress (93). Consequently, in 2014, Kenya was categorised as a low-middle-income 
country (94).  
Despite progress in reducing poverty, current poverty rates are still high compared with other 
low-middle-income countries. An annual poverty reduction rate of 6.1% would be required 
for Kenya to eliminate extreme poverty by 2030. However, in the last decade Kenya has only 
reached a 1.6% annual poverty reduction (94). Furthermore, the Kenyan population is rapidly 
growing, with an annual growth of about 2.3%. In 2019, the population reached 47.5 million 
(95). Kenya has a young population, with 43% of the population under age 15 (96). Most 
Kenyans practice Christianity (86%) and have a strong community-oriented culture (97). The 
total fertility rate in Kenya is 3.9; however, fertility varies dramatically with level of 
education. Women with no education have an average of 6.5 children, compared to women 
with higher education, who have an average of 3.0 children. A similar trend is seen among 
women from the poorest households (total fertility rate 6.4) compared to women from the 
wealthiest households (total fertility rate 2.3) (98). The contraceptive prevalence rate is 
estimated to be 43% among all women of reproductive age (15–49 years) and 58% among 
married women only. Figure 1 illustrates that women marry earlier than men. Average age at 
marriage among Kenyan women increases with education. On average, both women and men 
have their first intercourse before marriage, and 15% of women and 21% of men had their 
first intercourse at age 15 (98).  
 
Figure 1: Median age at first sex, marriage and birth 
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Unmet need for contraceptives is high among adolescents aged 15–19 in Kenya. In 2018, it 
was estimated that, among the 2.8 million women aged 15–19, 665,000 (24%) had a need for 
a contraceptive method. In other words, they are sexually active and do not want a child for 
at least two years but do not use a modern contraceptive method. This age group accounts 
for 86% of all unintended pregnancies in the country (99).  
Polygynous union is common in Kenya. Among women aged 15–49, 11% reported that they 
have at least one co-wife. This is most common among women with no education (98). 
Although Kenya ranks 109 out of the 153 countries in the “Global Gender Gap Report 2020”, 
significant gender inequalities remain (100). Kenyan society is highly patriarchal, 
particularly in rural areas. This originates from the traditional African lifestyle, where women 
have a low status and are supposed to take care of the children and household duties (101). 
Women are disproportionately poorer than men and often unaware of their rights. Today 
Kenyan women are still economically dependent on men, and women’s empowerment is 
challenged by lack of education, early or child marriage, gender-based violence, sexual 
violence, harassment and rape, and female genital cutting (94, 98).  
 
2.8.2 The health policy and health service delivery  
 
The overarching legal framework for health care delivery in Kenya is the 2010 Constitution 
of Kenya. The Constitution emphasises a rights-based approach to health where all Kenyans 
have “a right to the highest attainable standard of health, which includes reproductive health 
rights” and where no one shall be denied emergency medical care” (102 p1).  
 
Also, the Government of Kenya has committed to Universal Health Coverage for essential 
services, including maternal, neonatal and child health, by 2022. Universal Health Coverage 
is one of the four big initiatives under Kenya Vision 2030, Kenya’s long-term development 
blueprint (103). The concept of Universal Health Coverage was already adopted in 2005 with 
the “Kenya Essential Package for Health” and an action-focused strategy for Primary Health 
Care. The Kenyan health-care system is structured around Primary Health Care and divided 
into six hierarchical levels: “(a) community services, (b) dispensaries and clinics, (c) health 
centres and maternity and nursing homes, (d) sub-county hospitals and medium-sized private 
hospitals, (e) county referral hospitals and large private hospitals, and (f) national referral 
hospitals and large private teaching hospitals” (104). The “Kenya Essential Package for 
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Health” has contributed to increased access to health-care services in Kenya from 41% in 
2013 to 55% in 2016 (104). 
 
Abortion services are rarely provided in the public health sector in Kenya. Similarly, 
provision of post-abortion care in public facilities in Kenya remains low, hindered by 
restrictions on abortion, intermittent service interruptions, poor availability of services, 
inequitable access to post-abortion care, and lack of capacity at primary health-care facilities 
to manage complications, leading to further complications (105). 
2.8.3 Maternal mortality  
 
Kenya has had a gradual decrease in the maternal mortality ratio from 2000 to 2017 (see 
Figure 2). In 2017, the maternal mortality ratio in Kenya was estimated to be 342 maternal 
deaths per 100,000 live births (16). 
 
Figure 2: Maternal deaths per 100,000 live births in Kenya 2000 to 2017  
 
Source: “Trends in maternal mortality 2000 to 2017: estimates by World Health Organization, 
UNICEF, UNFPA, World Bank Group and the United Nations Population Division” (16) 
 
Despite these impressive national achievements in maternal mortality, regional differences 
within Kenya demonstrate vast inequalities. National data indicates that 98.7% of the total 
maternal mortality in Kenya is found in 15 out of 47 counties (106). According to the 2014 
Kenya Demographic Health Survey, unsafe abortion is the foremost contributor to the high 
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2.8.4 History and legal regulation of abortion in Kenya  
 
Kenya has an abortion law dating from the colonial time of British rule. Under the 1970 Penal 
Code, abortion in Kenya is criminalized, and abortion is legal only when a pregnant woman’s 
life is in danger. The Penal Code imposes penalties of up to fourteen years’ imprisonment for 
the abortion provider and seven years’ imprisonment for women or girls who have abortions 
in any other circumstances (107). “The African Charter on Human and Peoples’ Rights on 
the Rights of Women in Africa (the Maputo Protocol)” (108) from 2003 is the main legal 
document regarding the rights of women and girls in Africa. The Maputo Protocol includes 
sexual and reproductive health and rights and is strong in its statement regarding fertility 
regulation and access to safe, legal abortion as a human right for women. Kenya ratified the 
Maputo Protocol in 2010, but placed reservations on Article 14(2C) within the Protocol that 
calls on states to:  
“take all appropriate measures to protect the reproductive rights of women by 
authorising medical abortion in cases of sexual assault, rape, incest, and where the 
continued pregnancy endangers the mental and physical health of the mother or life 
of the mother or the foetus” (108). 
However, the “National Guidelines on Management of Sexual Violence in Kenya” allow 
abortion in cases of rape or violation (109).  
 
Abortion in Kenya was only legally allowed to save the life of a woman until 2010, when the 
revised constitution was adopted. The new constitution permits abortion when “in the opinion 
of a trained health professional, there is need for emergency treatment, or the life or health 
of the mother is in danger, or if permitted by any other written law” (110). However, as of 
today, the Kenyan Penal Code criminalizes abortion, while the constitution from 2010 
theoretically allows abortion. This conflict creates an ambiguous legal environment (111). 
As the abortion law in Kenya is not harmonized, this creates confusion among health-care 
providers, and ultimately women and girls are affected by poor access to safe abortion (112). 
The contradiction could be one of the reasons for the slow implementation of the new 
constitution and could affect health-care providers’ attitudes and perceptions of abortion. 
2.8.5 Abortion and contraception  
Unsafe abortion is a huge public health issue in Kenya, with 464,000 abortions induced 
annually and a national abortion rate of 48 abortions per 1,000 women of reproductive age 
(15–49) (113). This figure is the highest among all sub-Saharan African countries; the 
regional abortion rate is 31 abortions per 1,000 women of reproductive age (42). The induced 
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abortion rate in Kenya is estimated to be the highest in the Rift Valley region and the 
combined Nyanza and Western region, including Kisumu County (113). 
To support the implementation of the 2010 constitution, the “Republic of Kenya Ministry of 
Medical Services” published the “Standards and Guidelines for Reducing Morbidity and 
Mortality from Unsafe Abortion in Kenya” in September 2012. Several stakeholders 
supported the ministry in its development. However, one year later, in December 2013, the 
“Director of Medical Services” withdrew the document without providing a justification. 
Furthermore, all in-service training of health-care providers on safe abortion care was 
suspended. In 2018, the civil society activists filed a petition against the withdrawal of the 
standard and guidelines. The High Court ruled in 2019 that withdrawing “Standards and 
Guidelines for Reducing Morbidity and Mortality from Unsafe Abortion in Kenya” had 
violated the rights to high-standard health care, and the Standard and Guidelines document 
from 2012 was restored in 2019 (114). The aim of the “Standards and Guidelines for 
Reducing Morbidity and Mortality from Unsafe Abortion in Kenya” is to provide support for 
evidence-based decision-making by reproductive health-care providers. The document has a 
strong emphasis on sexual and reproductive health services, information, and education for 
adolescents and youth (115).  
According to the “Standards and Guidelines for Reducing Morbidity and Mortality from 
Unsafe Abortion in Kenya,” doctors, nurses, midwives and clinical officers with appropriate 
training can provide first-trimester abortion and post-abortion care (from gestation up to 12 
weeks) by vacuum aspiration, with misoprostol alone, or with misoprostol in combination 
with mifepristone. Second-trimester abortion and post-abortion care (from 13 to 27 weeks) 
can be provided only by skilled medical officers in consultation with a gynaecologist by 
dilatation and evacuation or with medical methods. The “Standards and Guidelines for 
Reducing Morbidity and Mortality from Unsafe Abortion in Kenya” also emphasises the 
importance of family planning counselling and services for all women receiving post-
abortion care services (115).  
To align with the “Standards and Guidelines for Reducing Morbidity and Mortality from 
Unsafe Abortion in Kenya” developed in 2012, the Kenya Essential Medicines List 2016 
included misoprostol in the oxytocics section for the first time. Misoprostol was indicated for 
use in the prevention and treatment of postpartum haemorrhage and excessive bleeding after 
childbirth, under close supervision. Mifepristone and misoprostol combined were included 
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in the oxytocics section but under the specialist list (116). In 2019, both mifepristone and 
misoprostol were placed under the Kenya Essential List 2019 (117). 
About 120,000 women seek post-abortion care annually to treat complications caused by 
unsafe abortion at health-care facilities (113). However, studies reveal that the complete 
package of high-quality post-abortion care service, which incorporates contraceptive 
counselling, is still not completely implemented in Kenya (118). As the abortion law is 
confusing in Kenya, health-care providers are reluctant to provide care, and they are also 
conservative and stigmatising in their attitudes towards abortion and post-abortion care 
services (86, 90, 119). Furthermore, post-abortion care is provided by faith-based 
organizations that refuse to provide contraceptive counselling. Consequently, clients are 
referred to family planning facilities, although such referrals have been demonstrated to be 
ineffective (120, 121). Health-care providers are also afraid of providing post-abortion care 
services because society might label them as abortionists (119).  
2.8.6 Stigma related to abortion and contraceptive use 
In Kenya, women and adolescent girls have poor knowledge and understanding of the legal 
context regarding abortion and the availability of safe abortion services. The common 
perception is that no abortion is safe. Abortion is surrounded by silence, secrecy and social 
stigma. Women and adolescent girls with unintended pregnancy fear stigmatisation and legal 
prosecution. Therefore, they hesitate to seek professional health care and opt for less-skilled 
abortion providers outside authorised health-care facilities, which frequently use outdated 
methods that are considered unsafe (122).  
Also, due to religious and cultural beliefs, post-abortion care providers often exclude 
evidence-based contraceptive counselling, as the Christian Church is traditionally against 
contraception (118). Many health-care providers strongly believe that premarital sex is sinful 
and that contraceptives are only for married women. Contraceptives are therefore not 
provided to adolescent girls, as it is believed contraceptives are physically harmful for this 
age group and associated with immorality and a promiscuous lifestyle (86). 
2.8.7 The education system and comprehensive sexuality education 
 
Education has a fundamental role in a nation’s economic and social development, as it 
contributes to individual growth, the capacity to create wealth and the ability to live a healthy 
life. An individual with an educational degree can enter a professional workforce, and this 
will contribute to quality of life. However, an individual’s basic cognitive skills are 
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dependent on the quality of the educational system. A weak educational system may therefore 
affect a nation’s human capital development (123).  
 
In 1964, one year after achieving its independence from Britain, Kenya implemented a 
centralized education system in line with the British education system. However, this system 
was replaced in 1985 by the current 8-4-4 system, which is aligned with the American system 
of education with “eight years compulsory primary education, four years of secondary 
education, and four years of higher education at a university” (124).  
 
In Kenya, primary education is high at 86% participation, but only 33% of students continue 
to secondary education, even though it is financially covered by the Government of Kenya 
(98). The gap between the proportion of females and males with no education is non-existent 
from age 10 to 14. About 4% of both girls and boys have no education between the ages of 
10 and 14. However, thereafter the gap steadily increases, and the total number of years of 
completed schooling is lower among women (5.8 years) compared to men (6.3 years). The 
proportion of individuals who have never attended school varies intensely across counties. 
In Nairobi, the capital, only 5% of all women have never attended school, while the 
proportion of women who have never attended school is 69% in North Eastern Kenya (98).  
In 2013, the Kenyan government committed to scaling up its comprehensive rights-based 
sexuality education (125). Furthermore, the National Adolescent Sexual and Reproductive 
Health Policy 2015 aims “to enhance the Sexual Reproductive Health status of adolescents 
in Kenya and contribute towards realization of their full potential in national development” 
(126). Some priority actions are stated in the Policy document, and three are directly related 
to this thesis: (a) to promote adolescent sexual and reproductive health and rights, (b) to 
increase access to sexual and reproductive health information for adolescents and age-
appropriate comprehensive sexuality education, and (c) to reduce adolescent pregnancy and 
unintended pregnancy (126).  
 
Although several supportive policies exist in Kenya, the implementation of sexuality 
education lacks comprehensiveness. Teachers have mainly focused on abstinence to promote 
HIV education, and the majority of the rights-based CSE subjects have not been taught at 
Kenyan schools. In other words, comprehensive sexuality education is a long way from being 
institutionalized in Kenya (127); therefore, adolescents and young people lack adequate 
information on basic sexual and reproductive health.  
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3 CONCEPTUAL FRAMEWORK  
 
The purpose of this conceptual framework (Figure 3) is to appreciate specific aspects of social 
phenomena in relation to stigma surrounding abortion and contraception. Inspired by several 
stigma researchers, I have used the social ecological model as an analytical lens for the levels 
of stigma associated with abortion and contraception at the individual, interpersonal, 
institutional, community and governmental levels. The model emphasises the complex 
interchange between factors at various levels and what drives and facilitates stigma 
associated with abortion and contraception.  
 
Figure 3: Conceptual framework on stigma surrounding abortion and contraception  
 




The social ecological model originates from the Ecological Systems Theory developed in 
1979 by an American psychologist and researcher, Urie Bronfenbrenner (131). The aim of 
the Ecological Systems Theory was to describe the relationship between children and their 
environment. Since then, countless researchers have modified the model. Social ecological 
models emphasise multiple levels of influence (such as “individual, interpersonal, 
institutional, community and policy”) (132), suggest interrelationships between levels, and 
suggest that behaviours both shape and are shaped by the social environment (132). This 
principle is in line with social cognitive theory concepts that emphasise the importance of an 
environment conducive to change in order to achieve change at an individual level. 
 
This thesis uses a variation on Bronfenbrenner’s model as the conceptual framework for 
stigma associated with abortion and contraception, with adaptations from Makleff et al. 
(128), Shellenberg (129), Stangl et al. (130) and Kumar et al. (44) and is outlined as follows: 
 
Governmental-level stigma: local, national and global laws, polices, strategies, and 
guidelines. International and national laws, policies, strategies, and guidelines regarding 
abortion and contraceptives can alienate and exclude individuals in need of these services, 
reinforcing the stigma surrounding abortion and contraceptive use. This overarching 
structural level includes policies and programmes at global, national and local levels, which 
are reflections of several social norms, attitudes, and beliefs that may fuel stigma associated 
with abortion and contraception. 
  
Community-level stigma: relationships and communications between organizations, 
institutions, churches, informal networks and neighbourhoods within a politically or 
geographically defined boundary. This level relates to the environment in the community 
and represents the context in which an individual lives. Stigma surrounding abortion and 
contraceptive use may be obvious and direct within social connections in the community, 
such as during religious ceremonies, in workplaces and schools, and while conducting 
recreational activities. Community norms, attitudes and beliefs regarding sexuality, fertility, 
and motherhood have been shown to influence communities’ views and perceptions of 
abortion and contraceptive use.  
 
Institutional-level stigma: stigma created or spread by institutional formal and informal 
rules, guidelines and norms. This level includes the climate in schools, health-care systems, 
administrations and organizations.  
 
 37 
Interpersonal-level stigma: perceived stigma by the partner, family members and friends that 
have the most immediate and direct impact on the individual. This includes schoolmates.  
 
Intrapersonal-level stigma: perceived stigma by the individual, self-judgement, or negative 
feelings such as shame and guilt. This level includes not only individuals who have 
experienced an abortion and adolescent girls using contraceptives but also individuals such 
as abortion providers and supporters of those women.  
As shown in Figure 3, all five levels of stigma in the conceptual framework are influenced 
and driven by legal context, cultural and religious beliefs, social norms and values, gender 
norms, and socio-economic status. All these drivers are relevant when identifying 





Women’s and adolescent girls’ right to reproductive health information, education and 
services are frequently violated, even though it is grounded in internationally recognized 
human rights treaties, along with women’s right to equality, the “right to the highest 
attainable standard of health” (12), the right to decide when to have children, the right to non-
discrimination, and the right to education (12, 13). All individuals have the right to freely 
make decisions about their bodies, free of coercion, discrimination and stigma (2).  
 
In western Kenya, early sexual debut, sexual activity without protection and unwanted 
pregnancy are major concerns facing women and adolescent girls. Despite the high 
occurrence of unwanted pregnancies and abortions in Kenya (113), there is a shortage of 
research that appraises a fundamental barrier to reproductive information, education and 
services—that is, social stigma associated with abortion and contraception. Abortion stigma 
has been conceptualized in the United States (84). However, insufficient theoretical and 
methodological tools exist to develop a profound understanding of the dilemma, particularly 
in low-income countries such as Kenya. Developing research tools to measure social stigma 
and designing interventions to reduce social stigma is a priority—not only from women’s 
and providers’ perspectives, but as a social and cultural process. Regardless of national 
policies and the growing knowledge base of evidence-based CSE, there is a large gap 
between policy and practice in Kenya. The Kenyan government supports provision of CSE, 
yet the policies largely promote an abstinence-only approach based on Christian and other 
religious beliefs. 
 
The present research project intends to explore the topics of interest with a mixed-method 
approach. By linking the results from Studies I, II, and III to the conceptual framework with 
a “stigma lens,” this PhD thesis will advance knowledge about constituents of stigma related 
to abortion and contraceptive use, and how this stigma can be addressed at secondary schools 
within the CSE programme. The long-term goal for the outcome of this thesis is to inform 
national and local strategies to reduce social stigma, which has direct consequences for 
improved access to abortion and contraceptive information, education and services, as well 





4.1 OVERALL AIM  
 
The overall aim of this doctoral thesis was to increase knowledge on the constituents and 
consequences of, and solutions to, social stigma surrounding abortion and contraceptive use 




I. To explore decision-making pathways preceding induced abortion among women with 
unwanted pregnancies in western Kenya. (Paper I) 
 
II. To analyse whether reporting a pregnancy as unplanned or planned is associated with 
contraceptive uptake, and to analyse predictors of unplanned pregnancy among women 
seeking post-abortion care in a low-resource setting in Kenya. (Paper II) 
 
III. To measure stigmatising attitudes surrounding induced abortion and contraceptive use 
among secondary school students in western Kenya. (Paper III) 
 
IV. To assess whether a stigma-reduction programme that promotes gender equitable 
norms and value clarification was effective in transforming attitudes and beliefs 
regarding abortion and contraceptive use among secondary school students in Kisumu, 
Kenya. (Paper IV) 
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5 MATERIAL AND METHODS 
 
The three research studies included in this thesis are two health-facility-based studies and 
one school-based study in Kisumu, Kenya. The first study used a qualitative design with in-
depth interviews. The second study was a cross-sectional study using data from a larger 
randomised controlled trial. The third study had a quasi-experimental design. Table 1 
describes the aim, design, participants and method used for data analysis for each study.  
 
Table 1: Outline of papers included in the thesis  
 Study I 













abortion: a qualitative 
study of women's 
experiences in Kisumu, 
Kenya 
Contraceptive uptake among 
post-abortion-care-seeking 
women with unplanned or 




a cross-sectional study of 
secondary school students 















abortion among women 
with unwanted 
pregnancies. 
To investigate contraceptive 
uptake among post-
abortion-care-seeking 
women reporting either 
planned or unplanned 
pregnancies and to identify 
factors associated with 
unplanned pregnancies 
To measure stigmatising 
attitudes surrounding 
induced abortion and 
contraceptive use among 
secondary school 
students. 
To test the efficacy of a 
school-based intervention 
for reduction of stigma 


















In depth interviews 
 
15 individual face-to-
face in-depth interviews 
using open-ended 
questions and a non-
judgmental approach  
Study nested in a 
randomized controlled trial 
on women who sought post-
abortion care in a low-





A classroom survey using 
validated questionnaires; 















 January 2014 to 
May 2014 











Nine women aged 19-32 
years old who had 
experienced an induced 
abortion  
Follow-up with 807 women 
at 7–10 days and with 472 
women at 3 months 
1207 secondary school 
students from two 
secondary schools in a 
suburban setting in 
western Kenya  
 
Two gender-mixed 
secondary schools in peri-
urban areas of Kisumu, 
Kenya. One intervention 
school and one control 
school were randomly 
drawn. In total, 1207 








. Inductive content 
analysis 




. Descriptive statistics 
. Binary logistic regression 
analysis  
. Descriptive statistics 
. Binary logistic 
regression analysis 
. Descriptive statistics 
. Analysis of variance 
(ANOVA) 
. Pearson chi-squared 
tests  
. Student t-tests 




5.1 THESIS SETTING  
 
In 2010, with Kenya's new constitution, the eight provinces were substituted by 47 counties 
and 209 sub-counties (132). Data collection for this thesis took place in Kisumu County, one 
of the 47 counties in the Republic of Kenya. According to the 2019 National Census, Kisumu 
County has a population of 1,156,000 people (95) and is divided into seven sub-counties. 
Kisumu is the third largest city in Kenya, with about 568,000 people, after Nairobi, the 
capital, and Mombasa, the coastal city. Kisumu city is the capital of Kisumu County and 
comprises three sub-counties: Kisumu East, Central and West. Kisumu County is a low-
income area with a high proportion (40%) of adolescents under the age of 15 (96). Despite 
its opportunities in the fishery industry, Kisumu city is one of the poorest cities in Kenya. 
Over 15% of its population has HIV/AIDS and around 60% lives in areas widely considered 
to be slums (98).   
 
Figure 4: Map of Kenya based on UN OCHA map  
  
Credit: UN Office for the Coordination of Humanitarian Affairs (OCHA) 
 
5.2 STUDY I AND II 
 
Study I and II aimed to explore decision-making preceding induced abortion and 
contraceptive uptake among women seeking post-abortion care in Kisumu, Kenya. The main 
objective of these two studies was not directly stigma; however, stigma was indirectly 
included and analysed.  
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5.2.1 Research process  
 
Study I and II were implemented within the “Department of Obstetrics and Gynaecology at 
Jaramogi Oginga Odinga Teaching and Referral Hospital” (JOOTRH) (level 5 county referral 
hospital) and Kisumu County Hospital (level 4 sub-county hospital), which are two public 
health-care facilities in Kisumu County. Altogether, the two facilities admitted around 20–
32 women per month with incomplete abortion and abortion-related complications during the 
study period. This number of women admitted to the two facilities is according to registered 
cases in line with ICD-10. However, as abortion is restricted in Kenya by their national law, 
reliable data regarding abortion is scarcely found in this setting.  
 
Study I was a qualitative study using in-depth interviews, while Study II was a cross-sectional 
study nested in a randomized controlled trial. When I joined the research team at Karolinska 
Institutet (KI), they had already established a strong working relationship with a local non-
governmental organization (NGO), “Kisumu Medical and Education Trust” (KMET), based 
in Kisumu, Kenya. I was assigned to lead the ethical approval process in collaboration with 
KMET in 2013. At that time, I lived in Nairobi, Kenya and visited Kisumu regularly to 
collaborate with the national staff at KMET for the start-up and implementation of the 
research project.  
5.2.2 Study I 
5.2.2.1 Instrument  
 
Based on research gaps identified in the literature and in collaboration with the research team 
at Karolinska Institutet and the local team in Kisumu, I developed a draft semi-structured 
interview schedule including open-ended questions and suggestions for probing. The 
questions were framed to collect data on women’s decision-making preceding induced 
abortion, plus how their social networks influenced them. The instrument was discussed with 
the research team and further enhanced. The instrument was also pilot tested on two 
participants and slightly modified before the initial data collection. (Appendix 1). 
5.2.2.2 Study population and sampling  
 
Midwives in the Obstetric and Gynaecological Ward at the two study sites were recruited as 
research assistants and supported the research team in identifying and approaching potential 
respondents between 1 January 2014 and 31 May 2014. The midwives had been trained and 
given clear inclusion criteria to be used for the purposive sampling of the study participants. 
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The inclusion criteria were: women over 18 years of age who had received post-abortion care 
at JOOTRH or Kisumu District Hospital or were admitted due to complications after an 
unsafe abortion and agreed to be interviewed. The midwives discussed with the women 
seeking post-abortion care their current pregnancy history and if they had induced the 
abortion. All women who met the inclusion criteria and were approached by a midwife agreed 
to participate. In line with ethical procedures, all women were informed about the purpose of 
the interview and assured of their confidentiality. In total, nine women aged 19–32 years 
were approached, and all agreed to participate in the study and were individually interviewed. 
Six of the nine women agreed to participate in a follow-up interview. Therefore, a total of 15 
individual, in-depth interviews took place. The decision to conduct follow-up interviews was 
made by the research team in hopes of developing rapport with the women and thereby 
improving our understanding of the subject. 
5.2.2.3 Data collection  
 
For the data collection, I collaborated with a postgraduate student in Global Health. I was 
based in Nairobi and co-supervised the master’s student while she conducted the in-depth 
interviews between February and April 2014. In total, six individuals were interviewed face-
to-face after their follow-up visit at the hospital 7–10 days after receiving post-abortion care. 
All interviews took place at the hospitals in a private room. Two individuals were interviewed 
at the time of the three-month follow-up visit, and one individual was interviewed while she 
was still admitted to the ward receiving post-abortion care. One participant needed an 
English–Luo translator. When conducting in-depth interviews concerning sensitive topics, 
repeated interviews can be additionally valuable. Therefore, we decided to offer a repeated 
interview to all informants approximately 2–5 weeks after the initial interview. In total, six 
respondents agreed to a second interview. Five of them were interviewed face-to-face at the 
hospital in a closed private room, while one respondent was interviewed over the phone due 
to logistical constraints. In this case, the interviewer was based in a private, closed room at 
KMET. Three respondents opted not to be interviewed a second time. The interviews lasted 
on average 45 min and were type recorded. Once theoretical saturation was reached, we 







5.2.2.4 Analysis  
 
The analysis was initiated by the transcription, which was conducted by me and the master's 
student verbatim. Directly after each interview, the master’s student who conducted the 
interviews made comprehensive field notes. In her field notes, she included reflections, initial 
thoughts and reactions to what she had heard from the participants. The field notes were also 
considered when conducting the analysis. The master’s student and I held daily virtual 
meetings in addition to follow-up meetings in Nairobi to review progress and discuss 
interview techniques. As a co-supervisor for the master’s student, I also provided mental 
support after emotional interviews and with respect to cultural challenges and constraints. 
We continuously reported back to the whole research team (Karolinska Institutet and KMET) 
via Skype and asked for additional guidance and support when needed. We used inductive 
content analysis, including open coding, category development and abstraction for analysing 
the data (133). The transcripts and field notes were read through several times by both of us. 
We identified meaning units and relocated them to an Excel document for classification into 
subcategories, generic categories and main categories. All members of the research team 
discussed the meaning units and categories to further improve the analysis and to maximise 
rigour.  
 
This qualitative research was essential for providing insight into decision-making pathways 
preceding induced abortion among women and adolescent girls with unwanted pregnancies, 
their experiences with stigmatisation, and how stigma impacted their decision-making 
process. The qualitative methodology is well-suited for investigating these themes that 
explore the “why” and “how” of women’s decision-making processes. 
5.2.3 Study II 
 
In conjunction with a large randomized controlled trial (134), we conducted additional data 
collection at the two hospitals during the provision of post-abortion care services.  
5.2.3.1 Instrument 
 
I developed a face-to-face questionnaire for Study II based on research gaps identified in the 
literature with support from supervisors and the local research team. This schedule was used 
to collect data for Study II after it had been pre-tested by trained midwives at the study sites 
(Appendix 2). The questionnaire was prepared in English and then translated into Luo and 
Kiswahili, two local languages in Kisumu. The questionnaire was back translated into 
English to safeguard the consistency of meaning. The background characteristics of the 
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participants comprised age, marital status, education, occupation, religion, gestational age, 
previous pregnancy and gravidity. The questionnaire was based on a series of questions, 
primarily: “Was this pregnancy planned, does anybody know about this pregnancy”, and “did 
your partner accompany you to the post-abortion care clinic?”. At the follow-up visit (7–10 
days after post-abortion care treatment), the midwives asked if the woman had selected any 
contraceptive method before discharge after the post-abortion care treatment. Women who 
answered that they had accepted a contraceptive method were then asked when they had 
started and what method they were currently using. Likewise, during the follow-up visit at 
three months, the midwives asked if the woman was still using a modern contraceptive 
method.  
5.2.3.2 Study population and sampling 
 
The eligibility criteria for the randomized controlled trial were women or adolescent girls 
with incomplete first-trimester abortions seeking post-abortion care at the two selected 
hospitals. The participants in the randomized control trial (N = 859) were randomly allocated 
to post-abortion care provided by physicians or midwives. Before initiating the randomized 
control trial, the providers were trained in a 5-day standardised post-abortion care service 
training programme. Before leaving the hospital, all participants were offered contraceptive 
counselling and their choice of a contraceptive method if they desired. All women were 
provided with a follow-up appointment after 7–10 days. In total, 810 women were eligible 
for Study II, as 49 women were lost to follow-up after 7–10 days. Also, three women did not 
provide information regarding pregnancy intention (unplanned vs planned pregnancy) and 
therefore were not included in the Study II (see Figure 5). Data collection took place from 1 
June 2013 to 31 May 2016. 
5.2.3.3 Analysis   
 
The variables were dichotomized, and descriptive statistics were used to describe the 
background characteristics in frequencies and proportions. Pearson’s chi-squared test (χ2) 
was used to assess whether there was a statistically significant difference between the two 
groups, women reporting unplanned pregnancies and women reporting planned pregnancies, 
with a significance level of p-value < 0.05. Finally, a binary logistic regression with odds 
ratios (OR) and 95% confidence intervals (CI) was conducted to explore factors associated 
with unplanned pregnancy.   
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Figure 5: Trial Flow Chart (published in Paper II) 
  
 
5.3 STUDY III  
 
Study III was implemented at two gender-mixed public secondary schools in Kisumu East 
and Central sub-counties in western Kenya. These schools are in the Manyatta and Nyalenda 
settlements, respectively. During data collection, the intervention school had approximately 
800 students enrolled over four streams, while the control school had about 700 students 
enrolled over three streams. Both schools base their education on Christian religious 




Study III aimed to measure stigmatising attitudes and beliefs regarding abortion and 
contraceptive use among secondary school students in western Kenya and to develop and test 
the efficacy of a school-based abortion and contraceptive-use-stigma-reduction intervention 
for Kenyan adolescents.  
5.3.1 Research process 
 
Study III was an intervention study using a quasi-experimental study design.  
5.3.1.1 Instrument  
 
For Study III, we used two validated scales: Adolescent Stigmatizing Attitudes, Beliefs and 
Actions (ASABA) and Contraceptive Use Stigma (CUS) (Appendix 3). The two scales were 
developed and validated by the research team at Karolinska Institutet (135). Both scales are 
based on the validated tool Stigmatizing Attitudes, Beliefs and Actions (SABA), an 18-item 
scale developed in 2013 by Ipas (136). The 18-item ASABA scale measures three dimensions 
of abortion stigma: negative stereotyping (8 items), exclusion and discrimination (7 items), 
and fear of contagion (3 items). The ASABA and CUS scales used a five-point Likert scale, 
and the students provided their answers from strongly disagree (1) to strongly agree (5). 
Therefore, each respondent had a summed response score reaching from a minimum of 18 to 
a maximum of 90 for the ASABA scale and a minimum of 7 to a maximum of 35 for the 
CUS scale. A higher score meant stronger agreement with the statement and therefore higher 
levels of stigma towards abortion and contraceptive use. As the school students came from 
two settlements in Kisumu County, we considered their families to be in a low socioeconomic 
position. As the research topic was sensitive, we wanted to ensure confidentiality and 
therefore only added age and gender as independent variables to the survey. We included two 
closed-ended questions regarding sexual behaviour: “Have you had your sexual debut 
(intercourse)?” and “Did you use any contraceptive method during your last intercourse?”.  
5.3.1.2 Study population   
 
A sample frame of 21 secondary schools within Kisumu County was screened, and 5 
secondary schools were selected, as they met the inclusion criteria and ensured comparability 
of communities with respect to baseline data. The schools had to meet the following 
characteristics to be considered for the study: (a) public secondary day schools of mixed 
gender, (b) located within a sub-urban area in Kisumu County, (c) hosting a minimum of 400 
students and (d) with Christian religious education, as this holds a key position in the Kenyan 
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school curriculum. One of the five schools that met the inclusion criteria declined to 
participate. Two schools were randomly allocated to be intervention and control schools. The 
principal statistician at the coordinating department at KMET wrote the four names of the 
schools on four pieces of paper and then mixed the papers and manually drew one piece of 
paper at a time. The first piece of paper drawn was assigned to be the intervention school, the 
second piece of paper to be the control school, and the two last notes were read for the sake 
of transparency. In total, a homogenous group of 1,207 students (Intervention School=555; 
Control School=579), aged 14–21 years, participated in Study III.  
In February 2017, the two scales (ASABA and CUS) were distributed as a self-reported 
classroom questionnaire survey among the secondary students at the two suburban secondary 
schools in Kisumu, Kenya. The data collected in February 2017 was used for the baseline of 
the quasi-experimental study and Paper III. The second and third data collection took place 
in March 2017 and February 2018, respectively, and was used for Paper IV. 
5.3.1.3 Analyses specific to Paper III 
 
In this paper, we wanted to measure stigmatising attitudes and beliefs concerning abortion 
and contraceptive use among secondary school students. We started the analysis by 
developing three age groups: 16–17 years, the average group (n = 590); 13–15 years, the 
younger group (n = 274); and 18–21 years, the older group (n = 328). The reasoning behind 
the groups was based on the education system, syllabus and social aspects regarding abortion 
and contraceptive use in Kenya, but also to disclose comparable age groups for statistical 
analysis.  
 
We used descriptive statistics to describe the study population and stigma scores. Pearson’s 
χ2 test was used to test the differences between age groups and between females vs males. 
An independent sample t-test was used to compare means. P-values equal to or lower than 
0.05 were considered statistically significant. All statistical analyses were performed using 
IBM SPSS Statistics for Windows, Versions 25 and 22.  
 
The answers on the ASABA and CUS scales were categorised into three groups, 1–2 (do not 
agree), 3 (unsure) and 4–5 (agree). We then calculated the summed scores and categorized 
the summed score of the ASABA scale as either high (summed score ≥ 46) or low (summed 
score < 46), and the summed score of the CUS scale was categorised as either high (summed 
score ≥ 19) or low (summed score < 19). The cut-off point was determined based on the 
median calculated on the total score for both the ASABA scale and the CUS. Binary logistic 
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regression analysis was used to assess the relationship between the dependent variable (high 
level of combined stigmatising attitudes on abortion and contraceptive use) and independent 
variables (gender and age). The associations were presented as OR with a 95% CI. 
5.3.1.4 Analyses specific to Paper IV 
 
In this paper, we aimed to assess the efficacy of a school-based stigma-reduction programme. 
We used Pearson’s χ2 test for categorical variables and the student t-tests for continuous 
variables to compare the characteristics between participants at the intervention school and 
the control school at baseline. We used ANOVA to analyse the differences among group 
means at the intervention school and the control school at baseline, 1-month and 12-month 
follow-ups. Changes in values were calculated by subtracting baseline values from the 
follow-ups. To evaluate the effect of the intervention, two sample t-tests were performed to 
compare total score changes (between baseline, 1-month and 12-month) between the 
intervention school and the control school. The detailed analysis for the two closed-ended 
questions regarding sexual behaviour [“Have you had your sexual debut (intercourse)?” and 
“Did you use any contraceptive method during your last intercourse?”] needed further 
analysis and therefore is not included in this thesis.  
5.4 ETHICAL CONSIDERATIONS  
 
The design and performance of each study were conducted in line with the World Medical 
Association Declaration of Helsinki (137). As this thesis is focused on a sensitive topic—
abortion-and-contraceptive-use stigma—several ethical considerations had to be weighed.  
 
For Studies I and II, the JOOTRH Ethical Review Committee in Kisumu (Diary Number 
ERC 42/13) and the Swedish Regional Ethics Committee in Stockholm (Reference number 
2013/902–31/1) granted ethical approval. For Study I, the participants (younger than 18 
years) provided their verbal and written consent in their preferred language (English, 
Kiswahili or Luo), and respondents were asked consent to use the tape recorder before 
starting the interview. Also, the interviewer made a concentrated effort to ensure all 
participants were informed about privacy, confidentiality, safe storage of the data and that 
they could withdraw their participation at any time with no consequences. This was vital to 
build trust and confidentiality and to encourage the participants to openly and freely share 
private and intimate information about unintended pregnancies, clandestine abortion 
procedures, and relationships with male partners. The midwives at the hospital ensured that 
all interviews could take place in a private room at the hospital without any disruption. One 
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interview took place with an interpreter (Luo) who was strictly informed about the 
importance of confidentiality. Only the authors to Paper I had access to the interview 
material. We chose to only collect key sociodemographic characteristics of the participants 
to protect their anonymity. All respondents were given small financial compensation to cover 
transportation costs. The amount was kept small so that the voluntary nature of participation 
would not be jeopardised. After the first two interviews, we realized that some women had 
complex social situations and needed counselling and professional support. Therefore, we 
discussed this issue with KMET, and they arranged such support for the women in need.  
 
For Study II, it was the midwives at the two hospitals that conducted the data collection at 
the follow-up visit 7–10 days after post-abortion care and again after 3 months. All midwives 
were trained to conduct the data collection according to ethical requirements and guidelines. 
Similar to Study I, we ensured that all participants were able to give informed consent, which 
included offering them information about the study aim and their right to pull out from the 
study at any time with no negative consequences. The consent form was read to all women 
in their preferred language (English, Kiswahili or Luo). All women signed the written consent 
form or marked the form with a thumbprint if they could not write their name. Study II was 
registered at Clinicaltrials.gov NCT01865136. 
 
Study III was approved by the JOOTRH Ethical Review Committee in Kisumu (Diary 
Number ERC.1B/VOL.I/263) and the Kenyan National Commission for Science Technology 
and Innovation. All participants were given the opportunity to provide informed consent 
(verbal and written) in English and Kiswahili language. As the study population included 
minors under the age of 18, we also asked for written consent from the tutors. All students 
were informed that they could leave the study at any time with no consequences. The 
questionnaires were collected with only the age and gender of the participants (no names) to 
ensure anonymity. We believe that this encouraged the students to honestly fill in the 
questionnaire. Study III was registered at Clinicaltrials.gov NCT03065842. All data for this 
thesis was handled according to Kenyan law and guidelines (138).  
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6 FINDINGS  
 
A brief overview of the study aim, outcome and main findings of this thesis are presented below 
in Table 2. A summary of the findings from Studies I–III follows the table. For further details, 
see the reprints of Papers I–IV attached at the end of this thesis. 
 
Table 2: Overview of study aim, outcome and main findings  
 Study I 




















reporting either planned 
or unplanned pregnancies 










To test the efficacy of a 
school-based 
intervention for 
reduction of stigma 








Three main categories:  
1) Reasons for induced 
abortion  
2) A culture of silence  
3) Choosing abortion 
despite risks and limited 
information. 
 
The outcome facilitated 
understanding of what 
stigma does to women 
and adolescent girls. 
Most women, regardless 
of reported pregnancy 





were young age (14–20 
years), unmarried status, 
no previous children, 
hidden pregnancy and 
absence of a partner at 
the clinic visit. At 3-
month follow-up, there 
was no difference in 
contraceptive use 






students in western 
Kenya. Stigma was 
more prevalent among 
male students and 
younger age groups 
compared to female 
students and older age 
groups. Abortion was 
considered a sin and 





consider promiscuous.     
The stigma score 
associated with 
abortion decreased 
between baseline and 
12-month follow-up at 
both intervention and 
control schools, with 
decreases of 28.2% and 
7.8%, respectively (p < 
0.001). The stigma 
score for contraceptive 
use decreased; the 
reductions at 
Intervention School and 
Control School were 
27.2% and 6.4%, 











Women expressed fear 
of social stigma and 
therefore made strategic 
choices about whom to 
trust regarding their 
abortion intention. This 
contributed to a culture 







surrounding abortion and 
contraceptive use may 
prompt women to hide 
pregnancy intention.  
 
An eight-hour stigma 
reduction programme 
based on gender 
equality, 
equitable norms, and 
value clarification can 







school-based CSE can 
lead to positive change 








6.1 STUDY I 
 
Three main categories progressed through the inductive content analysis: (a) reasons for induced 
abortion, (b) a culture of silence and (c) choosing abortion despite risks and limited information. 
The findings are presented under these three main categories with generic categories and quotes 
from the respondents. Figure 6 illustrates how the generic and main categories are related.  
 
Figure 6: Generic and main categories (modified from figure published in Paper I)  
 




1) Reasons for induced abortion 
The first main category is defined through four generic categories: (a) financial inability to raise 
a child, (b) social pressure associated with mistimed pregnancy, (c) perceived lack of options, 
and (d) disagreement between partners and abortion without the woman’s consent. 
 
Financial inability to raise a child: The participants in this study emphasized that their 
pregnancies were mistimed, unplanned or unwanted at the time they realized they were 
pregnant. A strong driving factor for opting for abortion was described by most women as a 
lack of financial stability for raising a child. “I was financially unstable to sustain those 
children.” (Respondent 8) Some respondents were concerned about losing their jobs if they 
continued with the pregnancy. “When [the pregnancy] is visible, you will be sacked. And when 
you are [alone] at home, who will support you? I have to work.” (Respondent 6) Similarly, 
young women that were living with their parents mentioned that they would be kicked out and 
not supported.  
 
Social pressure associated with mistimed pregnancy: Unmarried participants mentioned that 
they were worried about negative opinions and attitudes from their families and friends if they 
were to find out about the pregnancy. “Because [---] okay, people usually talk; in Kenya people 
will talk. Where you are staying, there are some people, those people like to gossip, people will 
definitely talk. [---] They’ll say you are still in your mother’s house [---] They won’t be able to 
understand…and some will even criticise your relationship.” (Respondent 5) 
 
The women participating in this study said that a stable partnership, as well as a supportive 
social network, were important during the decision-making process. The women needed both 
financial and couched support. Male partners had a key role in this process and directly or 
indirectly influenced the women’s decisions to opt for induced abortions. Unstable partner 
relationships were a common reason for deciding to have an abortion. “I already have two 
children; I am everything for these children… I am the mother and the father for these two 
children, so a third one would be too much problem. I just decided. I have to because that man 
never convinced me; I was not convinced at all that that man would provide anything.” 
(Respondent 6) 
 
Perceived lack of options: Women expressed feelings such as guilt, distress, shame and self-
blame because abortion was perceived as something wrong and immoral. “I felt bad because it 
was like murdering someone, but [---] I felt part of killing the kid because [---] I felt miserable 
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for like a week [---] two weeks.” (Respondent 2) Nevertheless, they could not see any option 
other than terminating the pregnancy due to their current economic, social or health 
circumstances. “I didn’t have any option because I just knew that the situation I was in [HIV 
positive]; I was not able to [---] take care of this baby [---] according to the situation [HIV 
positive] now I was in.” (Respondent 7) 
 
Disagreement between partners and abortion without the woman’s consent: The respondents 
mentioned that they had a different feeling about the pregnancy compared to their partners. 
Some women never told their partners about the pregnancy, as they knew the partners were 
strongly against abortion in general, and they feared the consequences. Single women had never 
told their ex-partners about the pregnancy.  
 
The most striking finding in this study was that more than one woman said they were forced or 
even misled by their partners to terminate the pregnancy. “He suggested for the abortion to be 
done; I told him no. [---] So he insisted, and he insisted. When he saw I’m not participating, he 
used a trick and told me that if you don’t want [an abortion] then I want to advise you on how 
to be when you are pregnant and what drugs [to] use. [---] He injected me through a vein and 
told me it’s to improve the appetite… [---] After injecting that drug I became unconscious. 
When I returned from my unconsciousness, I found myself naked and I was bleeding.” 
(Respondent 1) Respondent 1 told us that she had reported her ex-partner to the police. We do 
not know if the police raised a case against the ex-partner. In this and other such cases of forced 
abortion, we cannot imagine how the partners would describe the situation and justify their 
actions; that is beyond the scope of this research. 
2) A culture of silence  
This main category, A culture of silence, evolved from two generic categories: (a) finding 
individual support while fearing public disclosure and (b) secrecy as a strategy to avoid social 
stigma. 
 
Finding individual support while fearing public disclosure: Women described the period after 
they realized they were pregnant as very stressful and they feared public discovery to some 
extent, but they also described a strong desire to tell someone about the pregnancy. This 
someone was in many cases a person the respondents could trust, like a sister or a friend who 
had also experienced an abortion. Respondents felt anxiety about the partner knowing about the 
pregnancy as they feared disagreement or abandonment. “I was doubting what to do and on the 
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other hand afraid of sharing with anybody. I believed if I share it with so many people some 
people will give me other advice, some will give me this; that’s why I ended up sharing with 
my sister that I’m staying with because I trusted her.” (Respondent 4) 
 
Secrecy as a strategy to avoid social stigma: The participants expressed distress about social 
isolation, judgment, discrimination and rumours if the abortion were discovered. Respondents 
thought that society would see them as “killers.” Fear of social stigma and discrimination were 
expressed by most respondents, including fear of segregation, being labelled as a prostitute and 
murderer, being accused of being unfaithful, and being considered unsuitable for marriage. “In 
campus if you get pregnant and your boyfriend says I cannot take care of the baby, I’m not the 
father and stuff, they will start saying you are just like the others [---] maybe you have sex for 
money? Maybe you don’t know the father of the kid? [---] So, they start calling you names like 
whore, slut [---] Someone says you are just a whore like anyone else, and after that everyone 
starts to isolate you [---].” (Respondent 2) This fear of harmful rumours, negative reactions and 
consequences created a culture of silence. The respondents desiderated trustful support and 
confidentiality.  
 
Christian values and beliefs were heavily significant in most of the interviews. Women raised 
the issue that abortion is a sin and not accepted in any case by the church. This was a 
fundamental reason for keeping the pregnancy and abortion secret. In the follow-up interviews, 
a few respondents declared they felt anxiety, guilt and worry when they attended church. They 
also repeatedly asked for forgiveness from God as they accused themselves of being sinners. 
“You see as a married woman [---] you see [---] it seems like the woman is not even ready for 
the marriage [---] so something is wrong with her that cannot be explained, so they [the 
husbands] don’t like it so easy; they see it as a sin, so there is no way I can tell about the abortion 
to him as I know the consequences can be bitter for me [---] when you do such thing [abortion] 
since you are giving away God’s blood, then you are trying to be like the Father. God gave you 
the child, and now you are removing it so it’s a sin because you are competing with God.” 
(Respondent 9) 
3) Choosing abortion despite risks and limited information 
The main category Choosing abortion despite being aware of the risks grew from three generic 
categories: (a) being aware of the risks related to abortion, (b) significant others and storytelling 





Being aware of the risks related to abortion: The abortion was described as a dangerous 
procedure, and all respondents mentioned they knew the health risks of opting for an abortion. 
Complications like death, infertility, infections, weakness and loss of body weight were 
commonly mentioned. The most common and emphasised complication described by the 
respondents was death. Abortion was frequently labelled as gambling with life and death: “I 
was [very] scared [---] because I know how dangerous it is. But I was like, okay—let it be, and 
if I’m going to die, so be it, that is how, that is my destiny now. [---] I had now decided; it’s 
either death or survival. I was ready for anything.” (Respondent 5) Although women understood 
abortion as risky and unsafe, they preferred this risk over continuing the pregnancy and giving 
birth.  
 
Significant others and storytelling as guides in selecting an abortion provider: Women selected 
their abortion provider through informal discussions with friends who had personal experiences 
of unwanted pregnancies and abortion. Although some women knew about the organisation 
Marie Stopes International, only a few of them could visit professional abortion providers due 
to financial constraints, and many chose to go to the pharmacy directly to get misoprostol. 
“When I was in high school, we used to have some cases [of abortion] so I had that knowledge 
from school, so I just decided to do it on my own. [---] I also knew about other methods, but I 
was afraid to use the others because I had not tried to do it before.” (Respondent 9) 
 
Unmet need for information concerning safe abortion methods: Evidence-based information 
about safe, simple and common abortion procedures were limited or non-existent. Women only 
knew about unsafe abortion, which was described as hazardous and possibly fatal. Instead of 
seeking professional health care, women reached out to the local chemist. “[Abortion is] when 
you take drugs [---]; traditional herbals also terminate the pregnancy. Some people take juice, 
highly concentrated juice [---] only those ones [are the abortion methods I know of].” 
(Respondent 6) “I didn’t know anything. I have a friend who went through it before [---], but 
she passed away two weeks after the abortion [---].” (Respondent 2).  
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6.2 STUDY II 
 
In total, 810 women and adolescent girls received follow-ups after their post-abortion care, and 
of them, 807 women and adolescent girls reported their pregnancies as unplanned, 375 (46.3%) 
or planned, 432 (53.3%). All women and adolescent girls who chose a modern contraceptive 
method (n=614) were invited for a check-up visit at three months. In total, 472 women and 
adolescent girls participated in the three-month follow-up visit. Participants’ sociodemographic 
characteristics are summarized in Table 3. 
 






Pregnancy n (%) 
Planned  
Pregnancy n (%) 
 
p Value  
Provider 
n 807  375  432  
Midwife  408 (50.6%) 191 (50.9%) 217 (50.2%) 0.842 
Physician  399 (49.4%) 184 (49.1%) 215 (49.8%) 
Age (years) 
n 799 371 425  
Mean (SD) 25.06 (5.62) 24.08 (5.93) 25.94 (5.20) 
Range 14–45 14–45 14–43 
14–20 169 (20.9%) 112 (29.9%) 56 (13%) < 0.001 
21–30  509 (62.8%) 210 (56%) 297 (68.8%) 
31–45  121 (14.9%) 49 (13.1%) 72 (16.7%) 
Marital status 
n 810 375 432 < 0.001  
Married or cohabitating 554 (68.45%) 164 (43.7%) 388 (89.8%) 
Single, divorced, 
separated or widowed 
256 (31.6%) 211 (56.3%) 44 (10.2%) 
Religion 
n 810 375 432 < 0.001 
Christian 796 (98.3%) 371 (98.9) 422 (97.7%) 
Muslim 14 (1.7%) 4 (1.1%) 10 (2.3%) 
Education 
n 810 375 432 0.090 
None or primary grades 
1–8 
242 (29.9%) 122 (32.5%) 119 (27.5%) 
Secondary education 367 (45.3%) 172 (45.9%) 193 (44.7%) 
Tertiary education 201 (24.8%) 81 (21.6%) 120 (27.8%) 
Occupation 
n 805 375 432 < 0.001 
Unemployed 379 (46.8%) 210 (56%) 168 (38.9%) 
Formal employment or 
self-employment 
426 (52.6%) 161 (42.9%) 263 (60.9%) 
Gestational age based on last menstrual period (weeks) 
n 810 375 432  
Mean (SD) 5.73 (4.97) 5.63 (4.81) 5.78 (5.12)  






n 810 375 432  
Mean (SD) 1.79 (1.72) 1.78 (1.98) 1.8 (1.47)  
Range 0–12 0–12 0–7  
0 223 (27.5%) 126 (33.6%) 96 (22.2%) < 0.001 
1–3 467 (57.7%) 188 (50.1%) 277 (64.1%) 
4+ 120 (14.8%) 61 (16.3%)  59 (13.7%) 
Parity (live births) 
n 808 374 431  
Mean (SD) 1.11 (1.36) 1.15 (1.56) 1.08 (1.57)  
Range 0–10 0–10 0–6  
0 356 (44%) 186 (49.6%) 169 (39.1%) < 0.001  
a) Data are n (%) unless otherwise stated.  




Women and adolescent girls who reported planned pregnancy (423, 97.9%) were more likely 
to have shared the information about the pregnancy compared to women who reported 
unplanned pregnancy (296, 78.9%, p < 0.001). Similarly, more women whose partners 
accompanied them for post-abortion care services reported planned pregnancy (318, 73.6%) 
compared to unplanned pregnancy (118, 31.5%, p < 0.001). While most women reported 
spontaneous abortion (miscarriage) (748, 92.3%), self-induced abortions were more frequently 
reported in the unplanned pregnancy group (50, 13.3%) compared to the planned pregnancy 
group (6, 1.4%; p < 0.001). 
 
Contraceptive uptake among post-abortion-care-seeking women 
Out of 807 women who came for the check-up visit at 7–10 days, 614 (75.8%) had chosen and 
initiated use of a modern contraceptive method. The distribution of women with unplanned 
(273, 72.8%) and planned pregnancies (338, 78.2%, p = 0.072) were similar. Also at three-
month follow-up, there were no significant difference in contraceptive use between the two 
groups, unplanned (161 (77.4%) and planned pregnancy 193 (73.7%, p = 0.350).   
 
Binary logistic regression to explore factors associated with unplanned pregnancy 
To explore the independent factors associated with unplanned pregnancy, a binary logistic 
regression (n = 781) was run and presented as OR with a 95% CI. The questionnaire included 
both previous pregnancy and number of live births. However, because of the high correlation 
between these two factors, only the live birth factor was included in the model. The factors 
associated with unplanned pregnancy were age of 14–20 years (OR 1.18; 95% CI, 1.05–2.82; p 
= 0.033), single/divorced/separated/widowed status (OR 9.15; 95% CI, 5.72–14.64;  p < 0.001), 
nulliparity (OR 1.97; 95% CI, 1.29–3.01; p = 0.002), hiding pregnancy information (OR 7.71; 
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95% CI, 3.30–18.01; p < 0.001) and partner not accompanying the woman to the post-abortion 
clinic (OR 3.17; 95% CI, 2.21–4.55; p < 0.001). The Hosmer-Lemeshow test (p = 0.810) and 
the Nagelkerke R Squared (p = 0.441) indicated that the model fit the data. 
6.3 STUDY III 
 
In total, 1,368 secondary school students were eligible for the study (intervention school = 644; 
control school = 724). Out of these, 1,207 responses were analysed, as they had also responded 
at the one-month follow-up. At the 12-month follow-up, 693 students were enrolled. Figure 7 
presents the study design.  
 

























Schools Assessed for eligibility 
(N=21) 
Schools excluded (n=17) 
   Not meeting inclusion criteria 
(n=16) 
   Declined to participate (n=1) 
 
Followed up at 12-month (n=1) 
• Participants analysed (n=323) 
    Lost to follow-up (n=251) 
Allocated school to intervention (n=1) 
 Received intervention (n=1) 
 Participants at baseline (n=644) 
 
 
Randomised frame (n=4) 
ENROLLMENT 
Followed up at 1-month (n=1) 
• Participants analysed (n=574) 
      Lost to follow-up (n=70) 
 
 
      Followed up at 1-month (n=1) 
      • Participants analysed (n=633) 
         Lost to follow-up (n=92) 
 
Allocated school to control (n=1) 
 Not received intervention  (n=1) 
  Participants at baseline (n=724) 
   Followed up at 12-month (n=1) 
   • Participants analysed (n=370) 







At baseline, the 1,207 secondary school students (618 females and 582 males) from the two 
schools were in the age range of 13–21, with a mean (M) age of 16.66 years (Standard Deviation 
[SD] 1.5). The mean age for males was 18.84 (SD 1.56), which was higher than the mean age 
for females, 16.48 (SD 1.45, p < 0.001). At baseline, there were differences between the two 
secondary schools in the mean values for all three subscales of ASABA (p < 0.001), but no 
difference in the CUS scores (p = 0.094). 
 












    Female n (%) 618 (51.5%) 293 (51.4%) 325 (51.6%) 
0.949 
    Male n (%) 582 (48.5%) 277 (48.6%) 305 (48.4%) 
Age, in years (M±SD)  16.4±1.5 16.9±1.5 0.001 
Mean (1-5) subscales of ASABA (M±SD)     
    Negative stereotypes, 8 items   3.41±0.76 3.50±0.72 0.037 
    Discrimination and exclusion, 7 items     1.79±0.65 1.90±0.67 0.005 
    Potential contagion, 3 items   1.83±0.78 1.95±0.73 0.005 
Mean (1-5) full scale (M±SD)   
    Total 18 items ASABA   2.52±0.55 2.62±0.52 0.001 
    Total 7 items CUS   2.68±0.83 2.75±0.74 0.094 
1-month follow-up 
    Female n (%)  293 (51.4%) 325 (51.4%) 
0.949 
    Male n (%)  277 (48.6%) 305 (48.4%) 
12-month follow-up 
    Female n (%) 363 (52.4%) 170 (52.6%) 193 (52.2%) 
0.902 
    Male n (%) 330 (47.6%) 153 (47.4%) 177 (47.8%) 
a) The analysis is based on responses to all questions in the table. 
b) The internal drop-out range was between 7–33 (0.6–2.7%). 
 
At baseline, most students agreed with sentiments in the Negative Stereotyping subscale, where 
the item “A girl who has an abortion is committing a sin” showed the strongest agreement 
(90%), followed by “A girl who has an abortion brings shame to her family,” with 73% 
agreement. For contraceptive-use stigma, the sentiments with strongest agreement were “A girl 
who uses contraception will encourage others to be promiscuous,” with 47% agreement, and “A 
girl who uses contraceptives will have problems when she decides to get pregnant,” with 45% 
agreement.  
 
Table 5 demonstrates the mean scores for the two stigma scales by gender at baseline. The 
results show that male students had higher mean scores (mean 47.56, SD 9.43) for negative 
attitudes towards abortion compared with female students (mean 45.04, SD 9.55), p < 0.000. 
Similarly, male students had a higher mean score for replies on contraception-use stigma (mean 
19.67, SD 5.17) versus female students (mean 18.41, SD 5.68), p < 0.000.  
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N = 1207 
Female 
n = 618 
Male 





Mean (SD) Mean (SD) Mean (SD) 
Full scale (18 items)  
  
18-90 46.27 (9.57) 45.04 (9.55) 47.56 (9.43) 0.000 
Negative stereotyping   
(8 items)  
  
8-40 27.68 (5.91) 27.43 (6.28) 27.96 (5.49) 0.125 
Exclusion and 
discrimination (7 items)  
  
7-35 12.94 (4.61) 12.17 (4.23) 13.74 (4.86) 0.000 
Fear of contagion  
(3 items)  
  
3-15 5.68 (2.26) 5.47 (2.14) 5.91 (2.36) 0.001 
CUS full scale (7 items)  
  
7-35 19.04 (5.48) 18.41 (5.68) 19.67 (5.17) 0.000 
a) The internal dropout had a range of 9–53 (0.7–4.4%). 
b) The analysis is based on respondents who responded to all items in the table. 
c) Pearson’s χ2 test was used, and the significance level was set at p < .05 
 
At baseline, 52.3% of the students had high abortion stigma scores (summed score ≥ 46), while 
the remaining 47.7% had low scores (summed score < 46). Similarly, 53.9% of the students had 
high stigma scores for contraceptive use (summed score ≥19), while the remaining 46.1% had 
low scores (summed score <19). Male students expressed higher abortion stigma scores (57.7%) 
compared to the female students (49.0%); p = 0.003. Also, stigma related to contraceptive use 
was more common among male students (58.5%) than female students (50.6%; p = 0.007). In 
addition, the youngest age group (13–15 years) indicated higher stigma scores for both abortion 
and contraceptive use compared with the older age groups.   
 
With the support of my main supervisor, I also conducted a binary logistic regression to assess 
the independent factors associated with stigmatising attitudes on abortion and contraceptive use. 
We adjusted for sex and age, and the results showed that male students had higher stigmatising 
attitudes versus female students (OR 1.68, p < 0.001), and similarly, the older students had less 
stigmatising attitudes compared to the youngest age group (13–15). Results were as follows: 
age 16–17 OR 0.77; 95% CI, 0.50 – 0.90, p = 0.009 and age 18–21 OR 0.58; 95% CI, 0.42 – 
0.80, p = 0.001 with 13-15 years as reference group.  
 
At baseline, the intervention school registered a mean total score of 45.2 for ASABA (min = 
18; max = 90) and 47.2 at the control school. At the 12-month follow-up after the stigma-
reduction intervention, the mean total score was 32.5 at the intervention school, with score 
decreases of 28.2%. Similarly, at the 12-month follow-up, the mean total score was 43.5 at the 
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control school, with score decreases of 7.8%, (p < 0·001). Among the girls at the intervention 
school, the decrease was 26.5%, compared to 7.3% for the girls at the control school. 
Meanwhile, the boys at the intervention school, show a 29.8% decrease, compared to 8% for 
the boys at the control school. The results show a significant decrease in mean total score for 
all items after providing the intervention, and a slight reduction in mean score in the control 
school for most of the 18 items. The intervention was considered effective for both girls and 
boys.  
 
Similarly, the mean total score for all seven items on the CUS was 18.8 at baseline for the 
intervention school and 19.2 for the control school (min = 7; max = 35). At the 12-month follow-
up after the stigma-reduction intervention, the mean total score was 13.7 at the intervention 
school, compared to 18 at the control school. The mean total score decreased by 27.2% and 
6.4%, respectively. Among the girls, the decrease was 25.2% at the intervention school, and 
7.6% at the control school. Among the boys at the intervention school the mean total score 
decreased 28.8% and less so at the control school (4.8%). The transformation was more 
prominent in the intervention school compared to the control school. In other words, 
stigmatising attitudes positively transformed among both girls and boys after receiving the 
stigma-reduction program.  
 







   Negative stereotypes 35.1% 8% < 0.001 
   Discrimination and exclusion 16.8% 6.8% < 0.001  
   Potential contagion 19.2% 6.2% < 0.001  
Full scales 
   ASABA 28.2% 7.8% < 0.001  
   CUS 27.2% 6.4% < 0.001  
 
To find out if the different aspects (subscales) of abortion stigma correlate, and if abortion 
stigma correlates with contraceptive-use stigma, we investigated the interclass correlations. The 
three subscales of the ASABA scale, the full ASABA scale, and the CUS scale showed a 
positive correlation that fluctuated between 0.322 and 0.866. Hence, the ASABA scale is 
positively related to the CUS scale (r = 0.543, p < 0.001). This means that when abortion stigma 
increases, contraceptive-use stigma also increases. This is particularly important, as 
contraceptive use is an effective method to prevent unintended pregnancy, unsafe abortion, and 
thereby maternal morbidity and mortality.  
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3.41±0.76 2.53±0.80 2.21±0.82 < 0.001 -1.29 (-1.40, -1,19) 
Discrimination 
and exclusion 
1.79±0.65 1.58±0·61 1.49±0.45 < 0.001 -0.36 (-0.43, -0,28) 
Potential 
contagion 
1.83±0.78 1.61±0.70 1.48±0.60 < 0.001 -0.40 (-0.50, -0.30) 
Full scales 
ASABA 2.52±0.55 2.01±0.58 1.81±0.54 < 0.001 -0.78 (-0.85, -0.71) 
CUS 2.68±0.83 2.23±0.78 1.95±0.70 < 0.001 -0.73 (-0.83, -0.63) 
aUsing two sample t-test for baseline and 12-month follow-up data;  




















3.50±0.72 3.32±0.80 3.22±0.76 < 0.001 -0.29 (-0.38, 0.22) < 0.001 
Discrimination 
and exclusion 
1.90±0.67 2.02±0.74 1.77±0.59 < 0.001 -0.16 -(0.24, -0.09) < 0.001 
Potential 
contagion 
1.95±0.73 1.92±0.80 1.83±0.69 < 0.001 -0.18 (-0.26, -0.09) < 0.001 
Full scales  
ASABA 2.62±0.52 2.62±0.52 2.42±0.52 < 0.001 -0.23 (-0.29, -0.17) < 0.001 
CUS 2.75±0.74 2.75±0.75 2.58±0.69 < 0.001 -0.22 (-0.31, -0.13) < 0.001 
aUsing two sample t-test for baseline and 12-month follow-up data;  
bUsing one sample t-test for changes (12-month – baseline) in each group;  






The overall aim of this doctoral thesis was to increase knowledge on the constituents and 
consequences of, and solutions to, social stigma surrounding abortion and contraceptive use 
among post-abortion-care-seeking women and secondary school students in Kisumu, Kenya. 
Both quantitative and qualitative methodologies were used to investigate and explore stigma 
surrounding abortion and contraceptive use. The findings from this thesis may be valuable to 
inform policy- and decision-makers with evidence regarding the consequences of stigma 
surrounding abortion and contraceptive use, as well as offering some solutions for reducing 
stigma among secondary school students.  
 
The main findings from this thesis will be discussed with respect to intrapersonal-, 
interpersonal- and institutional-level stigma, the theoretical framework of which is discussed 
under conceptual framework and a schematic presentation of which is shown in Figure 3. 
Subsequently, the methodological limitations of the three studies will be delineated. 
7.1 INTRAPERSONAL-LEVEL STIGMA 
 
Study I focused on intrapersonal-level abortion stigma and how gender-based norms and 
Christian values influence Kenyan women’s decision-making preceding an induced abortion. 
Respondents in Study I expressed concern about disclosing the pregnancy and abortion for 
fear of judgment, social isolation, loss of social respect and even divorce. Similar findings 
have previously been reported among young unmarried women in Ethiopia (140), where 
silence regarding pregnancy and abortion was reported as a norm and an “intra-subjective 
process.” Furthermore, a systematic literature review on abortion stigma found that secrecy 
as a strategy was frequently used by women and adolescent girls to mitigate abortion stigma 
(85). Shellenberg et al. argued that fear of judgment effectively curtailed women’s readiness 
to disclose their abortion intention or experience (141). The respondents in Study I coped 
with the risk of stigmatisation by making strategic choices regarding whom they confided in. 
The expressed fears of negative rumours and a lack of trust in friends and relatives confirm 
social stigma, but also show that other individuals’ opinions are extremely important to 
women during the reproductive decision-making process.  
 
Respondents in Study I reported that they preferred to keep the pregnancy undisclosed to 
avoid revealing their wish for undergoing abortion procedures, which was also indicated in 
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Study II. In Study I, we found that young unmarried women faced “triple stigma”: the stigma 
of a premarital sexual relationship, pregnancy outside of marriage and abortion-related 
stigma. The intrapersonal-level abortion stigma significantly affects women’s decisions of 
whether to seek care from a professional health-care provider who offers a safe abortion or 
to seek an unsafe abortion clandestinely to avoid judgment. That fear of stigma related to 
unintended pregnancy, including the shame that may afflict the family and the risk of social 
sanctions and discrimination, has previously been suggested as a driving factor in women 
seeking clandestine, unsafe abortions (122, 141, 142). As shown in Study I, many of these 
women finally ended up at public health-care facilities with complications due to unsafe 
abortion procedures. At the facility, they hesitated to disclose their actions due to fear of 
stigma and discrimination. This may increase the risk of morbidity and mortality due to the 
delay in seeking professional care.  
7.2 INTERPERSONAL-LEVEL STIGMA 
 
Study III demonstrated that stigmatising attitudes towards abortion and contraceptive use are 
common in Kenya. Negative stereotypes such as believing that abortion is a sin, that abortion 
brings shame to the girl’s family and community, and that contraceptive use is associated 
with a promiscuous lifestyle that influences other peers were the sentiments with strongest 
agreement. Fear of contagion, as well as exclusion and discrimination towards girls who have 
had an abortion, were other dimensions with moderately strong agreement among secondary 
school students. Not surprisingly, abortion stigma was shown to be positively related to 
contraceptive-use stigma; consequently, when negative abortion stigma increases, negative 
attitudes towards girls using contraceptives also increase. Negative stereotypes and 
discrimination were slightly more prominent among the male students than among the female 
students.  
 
These findings correspond with previous studies from Uganda in which men reported lack of 
support towards women undergoing abortion (143). The male partner is often the primary—
and sometimes only—person aware of the woman’s unintended pregnancy, as seen in Study 
I. Though Study I only included women who had received post-abortion care, the respondents 
expressed limited decision-making power regarding their sexual and reproductive health; 
instead, decisions about their fertility plans rested mainly with their partners.  
 
Women’s decision-making power regarding abortion is hindered by gender norms and power 
imbalances (143). The drivers for abortion stigma among males and reasons for not 
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supporting women with unintended pregnancy can be fear of being arrested, fear that the 
woman would die and men’s personal beliefs against the practice. The sociocultural norms, 
values, religion and legal environment are found to contradict abortion and reflect men’s 
attitudes towards abortion (143). These gender power imbalances reflect the Kenyan 
patriarchal society, a society with a social system where men hold primary power as heads 
of the household, as well as political leadership and control of property (101). It is therefore 
central to address men’s attitudes, values and role in women’s reproductive and contraceptive 
agency and decision-making power. In addition to national efforts to prevent unintended 
pregnancy and unsafe abortion, different programmes and initiatives ought to challenge the 
patriarchal traditions that influence women’s access to safe abortion and contraceptives.  
7.3 INSTITUTIONAL-LEVEL STIGMA 
 
Institutional barriers such as policies and procedures may hinder access to care (130, 144). 
Study II primarily focused on institutional-level stigma surrounding abortion and 
contraceptive use. The study explored the uptake of modern contraceptive methods among 
women seeking post-abortion care who reported the pregnancy as unplanned versus planned. 
Uptake of modern contraceptives was expected to be less among women who stated the 
pregnancy was planned, as the assumption was that they would want to attempt for another 
pregnancy. However, we found no significant difference, suggesting that women reported the 
pregnancy as planned and indirectly claimed spontaneous abortion to avoid disclosing an 
induced abortion. Fear of stigmatising attitudes and legal repercussions may explain why 
most women seeking post-abortion care in Study II reported the pregnancy as planned when 
it may have been an unplanned pregnancy. 
 
Post-abortion care providers need a complete disclosure of women’s pregnancy history for a 
comprehensive choice of care. However, stigma creates distress among clients, leading to 
incomplete disclosures of their pregnancy history, which in turn leads to misappropriate care 
with potential risks for the client, as has been demonstrated before (105). Study II concluded 
that when women are offered contraceptive counselling and access to contraceptives as part 
of the post-abortion care service, most women, regardless of reported pregnancy intention, 
started to use a modern contraceptive method. These findings are important because women 
are not always offered these services (118, 145), even though contraceptive counselling is 
one of the mandatory elements of post-abortion care (64). Considering this context with 
restrictive laws and social stigma surrounding abortion, post-abortion-care-seeking women 
reporting the pregnancy as planned should not be interpreted as having no need for 
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contraception. Contraceptive counselling should be routinely provided to all post-abortion-
care-seeking women, regardless of their reported pregnancy intention. Health-care providers 
ought to understand the realities of women and adolescent girls, in order to adapt and modify 
their care to the needs and preferences of their patients. Study II included adolescents and 
young people; this is a diverse group with divergent needs, and it is fundamental that health-
care providers, managers and policy-makers understand and address barriers to access and 
use of contraception by this group of individuals (146).  
 
Adolescents and young people have the right not only to sexual and reproductive health care 
but also to information and education (1). A natural space for sexual education is the school, 
an institution for providing general education where the adolescents and young people spend 
a large portion of their time. The school social climate includes norms, values and 
expectations. Many researchers have been able to demonstrate that the school climate has a 
direct impact on students’ attitudes and behaviour (147, 148). Study III (Paper III) indirectly 
measured institutional-level stigma at two secondary schools. The findings revealed that 
stigmatising attitudes and beliefs about abortion and contraceptive use are common among 
secondary school students. Many respondents expressed that contraceptive use was only for 
married women, and if used by unmarried women, it was associated with immorality and 
promiscuity. Abortion was considered a sin and shameful for the whole family and the 
community. School climate as a group phenomenon has been extensively studied (148); 
however, in relation to abortion-and-contraceptive-use stigma, this thesis is the first.  
 
As shown in Paper III, the youngest age group (13–15 years) showed the highest level of 
stigmatising attitudes towards girls associated with abortion and contraceptive use, compared 
to older age groups. Stigmatising attitudes may become less as adolescents and young people 
themselves are faced with decisions about sexual relationships, contraception and unintended 
pregnancy. In Kenya, the majority of the population adheres to Christianity (86%) (97), and 
the schools included in the study provide Christian religious education. Therefore, it is not a 
surprise that Study III found that most (89.9%) students considered abortion a sin, while 
contraceptive use was expressed as morally wrong. Adolescent girls who use modern 
contraceptives were considered promiscuous (40.8%) and a bad influence on other girls 
(46.9%). These negative attitudes by peers may create a barrier to adolescent girls in need of 
comprehensive abortion care and/or contraceptive services. However, Paper IV showed that 
a school-based stigma-reduction programme for abortion and contraceptive use that 
promoted gender equality and equitable norms was effective in transforming attitudes and 
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beliefs regarding girls associated with abortion and/or contraceptive use. Even though the 
level of stigma was higher among male students compared to female students at baseline, the 
reduction in stigmatising attitudes and beliefs was greater among boys compared to girls. The 
stigma-reduction intervention provided in Study III was considered effective among boys 
and girls and could be implemented as part of the CSE programme in Kenya. Previous 
researchers have suggested that age-appropriate sexuality education programmes in Kenya 
need to be developed based on the latest evidence from effective programmes (127). Still 
today, abstinence-only-until-marriage programmes are common in Kenyan schools (127), 
even though this type of programme has been proven to be ineffective and ethically flawed 
and is best provided in combination with evidence-based information about sexual and 
reproductive health and rights (149). Adolescents have the right to information and to decide 
for themselves when to initiate sexual relationships, when to have children and when to get 
married. Abstinence can be a healthy option; however, it must be a free choice not forced 
(149).  
7.4 STIGMA – SOCIAL AND CULTURAL PROCESSES   
 
This thesis contributes to the broader understanding of stigma surrounding abortion and 
contraceptive use that identifies stigma as social-cultural processes. Social and political 
power influences individuals and outlines the stigma within all levels of society 
(Intrapersonal, Interpersonal, Institutional, Community and Governmental). The effects from 
the sociocultural environment can be observed and measured within the individual. The 
consequences of the intrapersonal-level stigma identified in this study, such as silence, 
concealment and fear of disclosure, are theoretically generated and driven by the 
sociocultural environment according to the Conceptual Framework (Figure 3). Improved 
knowledge and understanding of the social and cultural processes that create stigma should 







8 METHODOLOGICAL CONSIDERATIONS 
 
The strength of this thesis is the mixed-methods approach to investigating stigma surrounding 
abortion and contraceptive use. Given the limited number of published research papers on 
this topic among post-abortion-care-seeking women and especially secondary school 
students, this approach was needed to advance our knowledge of this multidimensional issue.  
8.1 STUDY I (PAPER I)  
 
This qualitative study was my first research study in Kisumu, Kenya and facilitated my 
personal understanding of what stigma does to women and adolescent girls. This study 
developed my interest in stigma surrounding abortion and contraceptive use. I was part of a 
multicultural research team and was involved from conception through data collection and 
analysis, which strengthens the trustworthiness of the findings. Trustworthiness in qualitative 
research has four criteria: credibility, transferability, dependability and confirmability. 
Credibility is when the researcher clearly links the findings with reality and shows that the 
results are true and accurate. One of the instruments to demonstrate this is triangulation and 
member checking. Transferability is when the researcher provides evidence that the findings 
may be applicable to similar or other populations and contexts. Dependability is about 
consistent and repeatable findings, and confirmability is about verifying that the findings are 
based on the respondents’ description rather than by the researchers. One technique to verify 
this is reflexivity, which may ensure transparency and quality (150).  
 
Credibility – truth value  
 
Study I was initially developed to explore decision-making in relation to induced abortion, 
contraceptive use, and experiences of post-abortion care among young women and their 
partners. We had planned to interview available partners separately. However, after 
conducting the first two interviews, we realized it was not ethically feasible to implement the 
study as initially planned due to confidentiality and privacy issues, as most respondents had 
kept their pregnancy status and/or the abortion a secret. It could be argued that this is a 
limitation of this study. Partners and other significant family members might have given 
different statements about the decision-making process. Ethical concerns prevented us from 
conducting interviews with the partners.  
 
Member checking could have been a valuable tool to confirm and demonstrate credibility in 
Study I. However, due to logistical constraints of conducting research in a rural, low-income 
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country such as Kenya, the research team lacked options to reach out to the participants a 
third time after the data was analysed and the draft manuscript developed. One can also 
wonder if the participants would have responded positively to hearing back from the research 
team more than a year after their post-abortion care.  
 
The use of suitable categories can also strengthen the credibility of a qualitative study. In 
Paper I, we demonstrated the abstraction process and how it covered the data. The data 
analysis, coding, category development and abstraction were conducted simultaneously by 
me and the master’s student. During this process, we held regular meetings with the whole 
research team to discuss and compare findings. This further improved the analysis and 
maximised the rigour of the study. 
 
Transferability – applicability  
 
The research project proposal focused on young women (15–24 years), but ethical concerns 
prevented the inclusion of adolescent girls under 18 years of age. Also, by coincidence, the 
selected sample for this study only included women over the age of 32. Older women and 
adolescent girls might have responded differently. Adolescent girls in Kenya are seriously 
affected by unintended pregnancies and unsafe abortions. They are the most affected age 
group; therefore, it would have been valuable to focus on, or at least include, some 
respondents under 18 years. The results might have looked different if the focus had been on 
adolescent girls and young women.  
 
Dependability – inquiry audit 
 
Dependability can be complicated, as it may be challenging to confirm consistent and 
repeatable findings. One way to do this suggested by scholars is to establish an external audit 
by having one or several external researchers reading, examining and reviewing the data 
collection process, data analysis, and the findings. This may confirm dependability. Before 
submitting this manuscript for publication, one of my supervisors not included in this study 
read the manuscript and provided critical feedback. Another way of conducting an inquiry 
audit could have been to organize a Journal Club. Unfortunately, at that time Karolinska 
Institutet was not open for Virtual Journal Clubs (as I was based in Kenya, I saw the value of 
connecting with my peers virtually). However, in late 2018, I prepared a Concept Note for 
Virtual Journal Clubs and managed to get the Doctoral School in Health Care Sciences at 
Karolinska Institutet interested in Virtual Journal Clubs. My main supervisor agreed to lead 
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the Virtual Journal Clubs, and together we started up the first Virtual Journal Club at 
Karolinska Institutet.  
 
Confirmability – reflexivity 
 
While conducting research, it is impossible to be “outside of” the study topic. Reflexivity 
regarding the researcher’s subjectivity in qualitative research is when you as a researcher 
recognize that you contribute to the research process. Reflexivity is about how we as a 
research team formed, and were formed by, the research process and outputs. To be better 
equipped and prepared for this study, I took two extra doctoral courses at Karolinska 
Institutet: “Interview techniques in health and care research” and “Practical approaches to 
qualitative research–based on blended learning.” During these courses, I learned that repeated 
interviews can lead to increased insight into informants’ feelings, thoughts and behaviour as 
trust was built between the interviewer and the respondent. When conducting in-depth 
interviews concerning sensitive topics, repeated interviews can be further valuable. 
 
For Study I (Paper I), five female researchers from Sweden and Kenya formed the research 
team. All of us had extensive experience in sexual and reproductive health and rights in low- 
and middle-income countries. This study benefitted from the shared experience, skillset, and 
energy that the team members brought. Personally, I also advanced my academic goals of 
learning from others across disciplines and departments at Karolinska Institutet in qualitative 
research.  
 
The unequal relationship between the researcher and the respondent should be considered in 
qualitative research (151). In Study I, the interviewer, a master’s student, was nonclinical and 
from outside the Kenyan health-care system. Therefore, it could be argued that this ensured 
participants’ confidentiality, as the study subject was a highly sensitive issue. After each 
interview, the master’s student would call me to discuss the case, and I let the master’s student 
debrief, which provided me with a deeper understanding of the interview.  
 
Conducting and transcribing the interviews was emotionally demanding. During the data 
collection and transcription of the interviews, I had daily conversations with the master’s 
student I co-supervised to provide guidance and support. We discussed our personal 
experiences and shared our feelings. The deep emotional experience of conducting the 
interviews and transcribing them allowed us to empathise and feel with the respondents. I 
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never met the respondents, and this helped me to stay away from my own feelings to truly 
analyse what the women meant.  
8.2 STUDY II (PAPER II)  
 
Study II (Paper II) had several strengths. First, this study had a large sample size and was 
nested within a large, randomised controlled study. Second, the sociodemographic 
characteristics of the women were heterogeneous. Third, this was an attempt to indirectly 
assess the consequences of women’s silence and fear of stigmatising attitudes by post-
abortion-care providers. Finally, as Kenya has a restricted abortion law, research on this topic 
is limited, and statistics regarding unplanned pregnancies are scarce.  
 
This study also had some limitations. One potential limitation is the low return rate at the 
three months follow-up. This may be due to poor access to the health-care facility. 
Transportation costs in Kenya are a barrier for women to access care. Other reasons for the 
low follow-up rate could be that women felt well and could not perceive the value of a follow-
up appointment with the midwife. The low follow-up rate at three months is a flaw and may 
indicate a dropout due to ceased contraceptive use or continued use with no need for further 
visits. 
      
Second, as this was a secondary analysis of existing data, a likely limitation was the 
availability of data. This may have led to missing relevant variables related to the concept of 
unplanned pregnancy. Unplanned pregnancy includes mistimed, unintended and unwanted 
pregnancies, and this definition was not indicated in the stated question. Although secondary 
data analyses unquestionably have limitations, they also increase the overall efficiency of 
research efforts, providing opportunities to explore and test relevant concepts when research 
funds are limited. Third, midwives asked the respondents about their pregnancy intentions 
retrospectively, which could have led to recall bias, a methodological issue.  
8.3 STUDY III (PAPER III AND IV)  
 
Study III (Paper III and IV) was a quasi-experimental study with three data collections. Both 
girls and boys participated in the study, and the analyses were gender- and age-segregated to 
avoid gender and age biases. The results were also segregated by school (intervention school 
and control school). Study III had several strengths, such as the design (quasi-experimental 
study with comparable groups), large sample size, and the same students were included at 
baseline and in the follow-ups 1-month and 12-month after the intervention. The 
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questionnaires we used were validated (135). Furthermore, as this was a supervised 
classroom survey, we encountered a low internal dropout rate, and the research assistants 
who supervised the data collection could ensure that the participants filled in their own 
questionnaires. The low internal dropout rate may confirm the validity and reliability of the 
instruments.  
 
Another important strength of this study was the extent to which it included the community 
(teachers, students, health-care providers, government officials from the Ministry of 
Education and Ministry of Health, religious leaders, and NGOs, as well as local and 
international researchers) in the development of the intervention. The intervention was 
therefore adapted to the cultural context. Also, teachers and principals from the schools 
included in the study and schools in the surrounding area hold ownership of the intervention 
and have requested support with implementation of the CSE programme. According to 
KMET, the teachers may have recognized they are not comfortable or fit to provide CSE to 
their students and have found this collaboration to be a fruitful way to support the students 
using evidence-based CSE with the aim of reducing stigma surrounding abortion and 
contraceptive use. 
 
Knowledge about secondary school students’ attitudes and beliefs towards abortion and 
contraceptive use is limited; this study contributes to the increase of that knowledge. This 
study is the first quasi-experimental study to study abortion-and-contraceptive-use stigma 
among secondary school students in a setting with restrictive abortion law and social norms. 
This study not only measured stigma but was also an interventional study, tailored to evaluate 
the impact of a stigma-reduction programme. Few interventional studies have addressed 
abortion-and-contraceptive-use stigma among adolescents and young people. In general, 
existing literature about abortion-and-contraceptive-use stigma interventions is limited (152). 
 
Despite several strengths, Study III also had some limitations. Quasi-experimental research 
design is like experimental research but without the randomisation of the intervention. Hence, 
quasi-experimental design will not remove the issue of confounding. In Study II, participants 
could not be randomly assigned to the intervention, and only two schools were included in 
the study; therefore, the sample size for a cluster randomised control trial was too small. 
However, quasi-experimental design is commonly used in field settings where random 





This thesis provides improved knowledge and understanding of the constituents of abortion-
and-contraceptive-use stigma, its consequences and solutions. The findings indicate that 
stigma acts as a driving force for unintended pregnancies and consequently unsafe abortions, 
which places women and adolescent girls at significant health risks. Women and adolescent 
girls seeking post-abortion care may fear stigmatising attitudes from health-care providers 
and consequently hide their pregnancy history. Therefore, all women and adolescent girls 
seeking post-abortion care should be provided routine contraceptive counselling to avoid 
repeated abortions. Additional attention during post-abortion contraceptive counselling 
should be provided to adolescents, unmarried women, nulliparous women, women with non-
disclosure of pregnancy, and women and girls attending the post-abortion care clinic without 
a partner, as they are more likely to have an unplanned pregnancy.  
 
A notable finding was that adolescent girls associated with abortion and/or contraceptive use 
are highly stigmatised among secondary school students. Negative stereotyping, 
discrimination and exclusion of girls who have undergone an abortion, as well as fear of 
contagion, are common sentiments among secondary school students. Stigma was more 
present among male students compared to female students. However, a three-session stigma-
reduction programme was effective among both female and male students in positively 
transforming negative opinions towards abortion and contraceptive use. This suggests that 
gender- and age-appropriate CSE should include an abortion-and-contraceptive-use stigma-
reduction module to reduce stigmatising attitudes among adolescents and young people.  
 
This thesis emphasizes that abortion-and-contraceptive-use stigma are sociocultural 
processes, multidimensional and flexible, and spread throughout all social levels. Therefore, 
this type of stigma should not be considered merely a phenomenon between individuals, as 
this might prove misleading and fail to represent the complexity of the issue. Drivers for 
stigma surrounding abortion and contraceptive use are inflated in the legal context, culture 
and traditions, religious involvement, social norms and values, gender norms, and 
socioeconomic status. A large social and cultural shift is needed to sustain the positive effects 
among school students seen in this thesis. Innovative strategies such as high-level policy 
changes, community dialogues and institutional advocacy are required for a stigma-free 
environment and to support women and girls navigating their sociocultural environment. 
 
 81 
10 RECOMMENDATIONS  
 
Future investment in research should consider stigma surrounding abortion and contraceptive 
use as a social-cultural process. To appreciate the complexity of health-related stigma a 
research team of individuals specializing in various fields should be established. The 
multidisciplinary research technique, with experts from different disciplines, could find 
explanations for the sociocultural processes by which large changes in norms and morals 
occur. Abortion stigma researchers should combine forces with other health-related stigma 
researchers (HIV/AIDS, mental health) to explore effective interventions that can be 
implemented at scale. Implementation science could support the development and application 
of effective abortion-and-contraceptive-use stigma reduction interventions in low-income 
countries.  
 
Governmental-level stigma  
• Improve understanding of stigma related to abortion and contraceptive use among policy 
makers at governmental level. 
• Explore and evaluate multi-level stigma-reduction interventions that normalize abortion 
and contraceptive use at all levels in the society, with the aim of transforming social views.  
• Explore a wide range of stigma-reducing strategies. 
• Investigate how national laws, policies and strategizes produce and reproduce stigma 
• Assess the association between stigma and social inequalities.  
• Improve understanding of the structural pathways to abortion-and-contraceptive-use 
stigma.  
• Explore the association between contraceptive-use stigma and abortion stigma at all levels 
in the society. 
• Investigate health consequences of abortion-and-contraceptive-use stigma, including cost 
analysis.  
• Improve understanding of stigma related to abortion and contraceptive use as a social 
determinant of health and health inequalities 
Community- and Institutional-level stigma 
• Evaluate rigorous stigma-reduction interventions in sexual and reproductive health and 




• Investigate abortion-and-contraceptive-use stigma at institutions other than health-care 
facilities, including preschools, secondary schools, health science institutions, and other 
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Appendix 1: Interview guide, Study I (Paper I) 
 
Post-abortion care and contraceptive counselling – facility-based studies in Kisumu, 
western Kenya.  
The aim of these interviews is to explore young women’s decision-making in relation to 
induced abortion and experiences of received post-abortion care. 
  
Interview guide Study I 
Date: ______________________       Time: ___________________________________ 
 
Interview nr: ________________       Health-Care Facility: _______________________ 
 
Sociodemographic information 
Age: ______________________ Educational background: ____________________ 
 
Current occupation: _________________________________________________________ 
 
Relationship status: ___________ If married (year and month): _________________ 
 
Partner’s occupation, if applicable: _____________________________________________ 
 
Religion: ______________________ Born in (rural or urban area): _________________ 
 
Current accommodation (independent or with family): _____________________________ 
 
Reproductive history 
Number of pregnancies: ___________         Number of live births: ____________________ 
 
Number of stillbirths: _____________         Number of miscarriages: _________________ 
 
Number of induced abortions: _______________ 
 






Can you please tell me about your situation? 
 
Probing questions: What made you realize that you were pregnant? What was your first 
reaction? How did you feel when you discovered that you were pregnant? Could you tell 




Can you share with me what has been on your mind during this pregnancy? 
 
Probing questions: What happened when you got pregnant? Who is the father? What is your 
relationship to him? Did you use any contraception? What was your opinion or knowledge 
about contraception? Have you ever used any contraceptives? 
 
Can you please describe to me the abortion decision and the procedure following your 
decision? 
 
Probing questions: When did you start thinking that you wanted to terminate the pregnancy? 
Do you feel that it was your own decision to induce abortion, or was anyone else involved? 
What did you know about abortion previously? 
 
Can you tell me more about your thoughts about the decision to have an abortion? Did you 
discuss the decision with anyone? Could you ask someone for advice or information? In that 
case, what did they say? Does your partner (if applicable) know of the pregnancy and the 
induced abortion? What was your partner’s opinion about the pregnancy and the abortion?  
 
Were there any other options for you other than abortion? Who paid for the abortion? Who 
conducted the abortion, where was it done and how? How many days ago did you have the 
abortion? Have you experienced induced abortion before?  
 
Did you have confidence in the provider? Did you feel safe? What were your fears?  
 
What are your thoughts and feelings about the abortion now? 
Do you feel worried/relieved? What do you worry most about? What was the most difficult 
part about the abortion? What was the easiest part? Can you share your thoughts with any 
close person (partner, sister, friend, parents)? 
 
Views about post-abortion care 
 
What is your opinion about the care during your stay at hospital? Can you describe the 
encounter with health-care providers at the hospital? What can be done to improve care? Did 




Do you think that I have missed something that you would like to add?  






Appendix 2: Face-to-face questionnaire, Study II (Paper II) 
 











1.1 Facility:  
Kisumu District Hospital             (  ) 1 
Jaramogi Oginga Odinga Teaching and Referral Hospital            (  ) 2 
 
1.2 Age in completed years  ..............................................  
 
1.3 Marital status           
Co-habiting/Married (duration):..............                 (  )  1 
Widow        (  )  2 
Single        (  )  3 
Divorced       (  )  4 
Separated                                                         (  )  5 
 
1.4 Religion:   
Christian       (  )  1 
Muslim         (  )  2 
 
1.5 Education level:              
None                                                            (  )  1 
Primary, 1-4                                                       (  )  2 
Primary 5-8       (  )  3 
Secondary                                                   (  )  4 
Tertiary                                                       (  )  5 
 
1.6 Occupation:                
Unemployed                                                 (  )  1 
Formal employment                                                   (  )  2 








Section 2:  Health care seeking 
 
2.1 How many days ago did this problem occur ? .................. (days) 
 
2.2 For this problem, have you sought health care anywhere else before coming to this facility?  
Yes          (  ) 1 (Go to 2.3) 
No          (  ) 2 (go to 3.1) 
 
2.3 If yes, from which facility level did you seek care? ...................................  
Private clinic             (  ) 1 
Dispensary             (  ) 2 
Health Centre                           (  ) 3 
District Hospital             (  ) 4 
Provincial hospital                                                                             (  ) 5 
Private Hospital             (  ) 6 
 
Section 3: Reproductive history 
 
3.1 Number of pregnancies:……………………………………… 
 
3.2 Number of deliveries:…………………………………………. 
 
3.3 Number of live birth:………………………………………….. 
 
3.4 Number of still births: ………………………………………… 
 
3.5 Number of miscarriages:…………………………………….. 
 
3.6 Number of induced abortions:……………………………….. 
 
 
3.7 Does anybody know about this pregnancy?  
Yes            (  ) 1   
No            (  ) 2  
 
 
3.8 If yes, who knows about it?  
Partner      (  ) 1 
Parent(s)       (  ) 2 
Other relatives       (  ) 3 
Friend(s)       (  ) 4 











3.9 Did your partner accompany you to the PAC clinic?    
Yes           (  ) 1    
No             (  ) 2 
 
3.10 Was this pregnancy planned?   
Yes           (  ) 1   
No             (  ) 2 
 
3.11 What contraceptive methods have you used in the past 12 month     YES     NO 
None                                                                                  (  )  (  ) 
Safe days (fertility awareness method)       (  )  (  ) 
Condoms                                                                            (  )  (  ) 
Contraceptive pills                                                              (  ) (  )  
Hormonal injections                                                            (  ) (  )  
Hormonal implants                                                             (  ) (  ) 
IUD                                                                                      (  ) (  )  
Permanent contraceptive                                                    (  ) (  ) 
 
Section 4: Clinical findings 
4.1 Gestational age based on last normal menstrual period (LMP) in weeks:…………… 
 
4.2 Gestational age according to size of uterus (in weeks):............................................. 
 
4.3 Symptoms at clinical findings    YES     NO 
Foul-smelling vaginal or cervical discharge                         (  )      (  )  
Abdominal pain                                                                    (  )      (  ) 
Foreign body in vagina         (  )      (  )  
Tears on portio         (  )      (  )   
 
4.4 Administer Misoprostol 600 mcg 
Yes                                                    (  ) 1 
No                                                     (  ) 2 
 
4.5 Administer Pain management 
Yes                                                    (  ) 1 









4.6 Administer Antibiotics 
Yes                                                    (  ) 1 
No                                                     (  ) 2 
 
4.7 Did you try to end this pregnancy? 
Yes                 (   ) 1 
No  (if NO go to 5.1)              (   ) 2        
 
4.8 If yes, which method(s) was/were used to end the pregnancy?           YES      NO 
MVA                                                                                   (  )         (  ) 
Dilatation & Curettage                                                            (  )         (  ) 
Catheter                                                                                (  )         (  ) 
Tablets/misoprostol       (  )         (  ) 
Sticks                                                                                     (  )         (  )  
Herbs, vaginal                                                                     (  )         (  )  
Herbs, oral                                                                           (  )         (  )     
 
4.9 Who induced the termination? 
Self        (  ) 1 
Family member                                                                      (  ) 2  
Traditional healer      (  ) 3  
Physician                                                                            (  ) 4  
Clinical officer                                                                               (  ) 5  
Nurse/midwife                                                                              (  ) 6  
Pharmacist                                                                             (  ) 7  
 
4.10 Where did you try to end the pregnancy?  
Public facility                                                                         (  ) 1  
Private facility       (  ) 2                                                                                                             
T raditional healer                                                                          (  ) 3 
At home              (  ) 4  
Private Hospital                            (  ) 5                                                                                    

























Study client number:…….. 
Section 5 Post abortion contraceptive counselling 
5.1 Received information about contraceptives at this admission 
Yes           (  ) 1 
No             (  ) 2 
 
5.2 Contraception accepted    
Yes           (  )  1 
No            (  )  2 
 
5.3 Contraceptive method chosen 
Condoms                                          (  )  1 
Contraceptive pills                          (  )  2 
Hormonal injections                         (  )  3 
Hormonal implants                                     (  )  4 
IUD                                                                      (  )  5 
Permanent contraceptive                 (  )  6 
 
 
6.1 Received post abortion information 
 
Yes                                                    (  ) 1 
No                                                     (  ) 2 
 
6.2 Discharge  time:………………………………………. 
 















Section 7: Follow up after 7 – 10 days, clinical findings and symptoms  
 








7.2 Blood pressure:…………………... 
7.3 Temperature in degrees:…………  
 
7.4 Reported symptoms after PAC     YES     NO 
Chill                                                                                 (  )        (  ) 
Foul-smelling vaginal or cervical discharge                      (  )        (  ) 
Lower Abdominal pain                                                          (  )        (  ) 
Nausea    (  )        (  ) 
Vomiting    (  )        (  ) 
Diarrhoea    (  )        (  ) 
None    (  )        (  ) 
 
7.5  Bleeding since the treatment 
 
Much less than normal menstrual bleeding                       (  )  1 
Less than normal menstrual bleeding                                (  )  2 
Same as normal menstrual bleeding                    (  )  3 
Heavier than normal menstrual bleeding                 (  )  4 
Much heavier than normal menstrual bleeding             (  )  5 
 
7.6 Number of days bleeding after treatment   ………………… 
 
 
7.7 Pelvic infection at follow up 
Yes     (  )  1  











7.8 Retained products  
Yes     (  )  1  
No    (  )  2 
 
7.9 If retained products 
Counselling and reassurance                  (  )  1  
MVA                                    (  )  2 
Repeat dosage of Misoprostol (600 mcg)                                    (  )  3 
 
7.10 Complete abortion  
Yes    (  )  1  






7.11 Pain assessment 
Ask the women to grade the severity of pain experienced following PAC   
None     (  ) 1 
Mild     (  ) 2 
Moderate     (  ) 3 
Severe     (  ) 4  
 
7.12 Did you use any other pain relief after treatment 
Yes         (  )  1  
No        (  )  2 
 
7.13 Did you have any unscheduled visits at health care clinic/hospital since treatment? 
Yes         (  )  1  
No        (  )  2  
 
7.14 Reason for the unscheduled visit    YES     NO 
Heavy bleeding         (  )       (  ) 
Feeling lightheaded/dizzy       (  )       (  ) 
Fever/Chills        (  )       (  ) 
Persistent sever abdominal pain      (  )       (  ) 
 











Section 8 Women’s experiences of treatment 
 
8.1 Did you receive information/counselling concerning symptoms following treatment? 
Yes         (  )  1 
No (if no go to 8.3)      (  )  2 
 
8.2 If yes, was the information/counselling 
Very adequate       (  )  1 
Adequate       (  )  2 
Insufficient       (  )  3 
Very insufficient       (  )  4 
 
8.3 Did you feel relaxed and safe after the treatment? 
Yes        (  )  1 
No        (  )  2 
 
8.4 How did you perceive the treatment procedure? 
As expected/ anticipated           (  )  1 
Worse than expected/ anticipated                      (  )  2 
Easier than expected       (  )  3 
 
8.5 Would you recommend the treatment to a friend or relative?  
Yes        (  )  1  
No        (  )  2 
 
 
Section 9 Post abortion contraceptive at follow up  
 
9.1 Did you receive contraceptive counselling before discharge after your treatment?  
Yes                   (  )  1 
No                    (  )  2 
 
9.2 Did you accept any contraceptive method?    
Yes                     (  )  1 
No                      (  )  2 
 
9.3 What contraceptive method did you choose? 
Condoms       (  )  1 
Contraceptive pills              (  )  2 
Hormonal injections            (  )  3 
Hormonal implants             (  )  4 
IUD         (  )  5 
Permanent contraceptive               (  )  6 






























9.4 Have you started using the chosen contraceptive method 
Yes        (  )  1 
No                       (  )  2 
 
 












9.8 Extra contraceptive counseling given     
Yes                     (  )  1 











Section 10. Post abortion contraceptive use at 3 month.  
 
10.1 Are you still using the chosen contraceptive method? 
Yes        (  )  1 
No (go to 10.3)      (  )  2 
 
 
10.2 What is the level of your satisfaction with the contraceptive method chosen (go to 10.8) ?  
Highly satisfied       (  ) 1 
Just satisfied       (  ) 2 
Not satisfied       (  ) 3 
Would like to stop method      (  ) 4 
 
 
10.3 Why did you discontinue the chosen contraceptive method? 
Wanted pregnancy      (  )  1 
No resupplies       (  )  2 
Partner refused       (  )  3 
Side effects       (  )  4 
 






10.4 Have you received counselling on the new method 
Yes        (  )  1 
No        (  )  2 
 
 
10.5 Which method do you use now instead? 
None        (  ) 1   
Condoms                     (  )  2 
Contraceptive pills             (  )  3 
Hormonal injections            (  )  4 
Hormonal implants               (  )  5 
IUD                                       (  )  6 
Permanent contraceptive                     (  )  7 





Study client number:…….. 
 
10.6 Are you comfortable with that new method? 
Yes        (  )  1 
No        (  )  2 
 
10.7 Pregnancy test taken 
 
Yes        (  )  1 
No        (  )  2 
 
 
10.8 Result of pregnancy test 
 
Positive        (  )  1 
Negative       (  )  2 
 




10.9 Extra contraceptive counselling given     
 
Yes               (  )  1 









Appendix 3: Questionnaire, Study III (Paper III and IV) 
ASABA Questionnaire 
 
Female                        Male            Age: …………. 
1= Strongly Disagree      2=Disagree 3=Unsure 4=Agree 5=Strongly Agree 
Negative Stereotyping SABAS items 
Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
1 A girl who has an induced abortion is committing a sin. 1 2 3 4 5 
2 Once a girl has one abortion, she will make it a habit 1 2 3 4 5 
3 A girl who has had an abortion cannot be trusted. 1 2 3 4 5 
4 A girl who has had an abortion brings shame to her family. 1 2 3 4 5 
5 The health of a girl who has had an abortion is never as good as it was before the abortion.  1 2 3 4 5 
6 A girl who has had an abortion might be a bad influence on other girls.      
7 A girl who has had an abortion will be a bad mother.  1 2 3 4 5 
8 A girl who has had an abortion brings shame to her community. 1 2 3 4 5 
 




Exclusion and Discrimination SABAS items 
Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
9 A girl who has had an abortion should be prohibited from going to religious services.  1 2 3 4 5 
10 A girl who has had an abortion should be teased so that she will be ashamed about her decision.  1 2 3 4 5 
11 A girl should be disgraced in my community if she has had an abortion.  1 2 3 4 5 
12 A man should not marry a woman who has had an abortion.  1 2 3 4 5 
13 A girl who has had an abortion should no longer be associated with 1 2 3 4 5 
14 
A girl who had an abortion should be pointed fingers at so that other people would know what she 
has done 
1 2 3 4 5 
15 A girl who has had an abortion should not be treated the same as everyone else.  1 2 3 4 5 
 









Fear of contagion SABAS items 
Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
16 A girl who has had an abortion can make other people fall ill or get sick 1 2 3 4 5 
17 A girl who has had an abortion should be isolated from other people in the community for at least 4 
weeks after having an abortion. 
1 2 3 4 5 
28 If a boy has sex with a girl who has had an abortion, he will most likely become infected with a disease. 1 2 3 4 5 
 








Female                       Male            Age: …………. 
1= Strongly Disagree      2=Disagree 3=Unsure 4=Agree 5=Strongly Agree 
 
Contraception SABAS items  
Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
1 
A girl who use a contraceptive method is promiscuous (sexually immoral, likes to have many sexual 
relationships).  
1 2 3 4 5 
2 A girl who use a contraceptive method will encourage other girls to be promiscuous  1 2 3 4 5 
3 A girl cannot decide for herself if to use a contraceptive method. 1 2 3 4 5 
4 A married woman is more deserving of a contraceptive method than an unmarried woman.  1 2 3 4 5 
5 A girl who uses contraceptives will have problem when she decides to get pregnant. 1 2 3 4 5 
6 A girl who carries condoms is likely to have many sexual partners. 1 2 3 4 5 
7 A girl should not insist to use a condom, it is the man to decide whether to use a condom or not. 1 2 3 4 5 
 





Sexual debut  
1 
Have you had your sexual debut (intercourse)?                                                            
No    Yes  
2 
If you have had sexual intercourse, did you use any contraceptive method(s) during your last intercourse (only applicable if you 
answered Yes on question 28)?                  
 No   
 Yes, I used:  
         
 






 Condom     
 Contraceptive pills             
 Hormonal injection 
 Hormonal implant 
 Other: …………………………………………………………………………………………………………....... 
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